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Abstract 
With the goal of enhancing the emission of ultra-sound (US) waves in 
photoacoustic imaging (PAI) for the detection of cancer we discovered an effective system 
for Förster Resonance Energy Transfer (FRET) composed of a near infrared fluorescent 
(NIRF) dye and a NIR quencher (NIRQ) dye separated by a polyproline peptide spacer.  In 
PAI, a newly developed imaging technique, the signal is generated by excitation of cells 
using pulsed infrared lasers and measurement of resulting US waves using detectors. NIRF 
dyes can increase the sensitivity of PAI signal, particularly when used in targeted molecular 
imaging agents (TMIAs). However, most of the energy of absorption is likely lost during 
fluorescence. Our hypothesis was that if the fluorescence could be quenched by FRET, all 
of the energy from the laser could be converted to a substantially stronger US signal from 
the NIR dyes. In FRET, an optimized distance between the NIRF and NIRQ dyes is 
essential, but has not yet been determined for this dual dye system. To determine the 
appropriate distance, we designed and synthesized a polyproline spacer as a rigid 
“molecular ruler”. Multiple polyproline spacers (di, tetra, octa) were synthesized and 
coupled first to two NIRF dyes, Cy5.5 and IR770TI, using a modular synthetic approach 
developed by our group. When the emission resulting from FRET between NIRF dye pairs 
was evaluated, a strong FRET effect was observed from the octaproline dye pair, with twice 
the signal as the tetraproline. Furthermore, it was found that the FRET effect could be 
influenced by the solvents due to the dye aggregation. The polyproline approach was then 
applied to the synthesis and evaluation of NIRF-NIRQ dye pairs resulting in the discovery 
that tetra and octaproline NIRF-NIRQ systems yield nearly complete FRET quenching. 
The new FRET system is a valuable tool for future research in PAI to provide a higher, 
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more sensitive signal.  Samples have been submitted to collaborators for evaluation using 
PAI instrumentation at nearby cancer research centers.       
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Abbreviations  
ACN (Acetonitrile, an organic solvent used in HPLC).  
CFM (Confocal fluorescence microscopy)  
DCL (Targeting Urea for Prostate)  
DCM (Dichloromethane) 
DSS(A linker in targeting molecular imaging agents)  
DEA (Diethylamine, a de-protecting agent for Fmoc) 
DIPA (diisopropyl ethyl amine, also called DIEA, used as a base in coupling reactions)  
DMF (Dimethylformamide, a solvent for peptide coupling) 
Fmoc (fluorenylmethyloxycarbonyl, a common peptide protecting group,) 
HATU (a common peptide coupling reagent) 
HPLC (High Pressure Liquid Chromatography)  
LC-MS (liquid chromatography – mass spectrometry)  
MeOH (Methanol an organic solvent used in HPLC) 
MRI (Magnetic Resonance Imaging) 
MS (Mass Spectrometry)  
NIR (Near-Infrared) 
NIRF (Near-Infrared Fluorescent) 
NIRQ (Near-Infrared Quencher) 
NMM (n-methylmorpholine, used as a base in coupling reactions) 
NMP (n-methylpyrolidine, a peptide coupling solvent) 
PAI (Photoacoustic Imaging) 
PCa (Prostate Cancer) 
PET (Positron Emission Tomography)  
λmax (Lamda Max, peak wavelength in UV-Vis-NIR absorption spectroscopy 
TBTU (a common peptide coupling reagent) 
TFA (trifluoroacetic acid, a common buffer, also used to remove protecting groups) 
THF (tetrahydrofuran, an organic solvent)  
TMIA:  targeted molecular imaging agent  
TSTU (a common peptide coupling reagent)  
UV-Vis-NIR (Ultra Violet – Visable – NIR absorption spectroscopy) 
Information on NIR dyes utilized  
Cy5.5 (NIRF dye absorbing at 680 nM and fluorescing at 710 nM, useful in CFM) 
IRdye800CW (NIR dye absorbing at 770 nM, fluorescing at 800 nM, a LI-COR product) 
IR770Ti  (NIR dye abs. at 770 nM, fla 770 nm, Ti refers to “Tiger Imaging” (RIT tiger)  
QC-1 (NIRQ dye with broad absorption from 750-820 nM, a LI-COR product) 
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Nomenclature of Peptides containing Dyes 
 
 Peptide and peptide-dye structures in this document are described by standard 
peptide nomenclature which may not be familiar to all readers.  In peptide nomenclature, 
the standard three-letter designations for amino acids are utilized. Peptides are 
conventionally drawn with the nitrogen of the first amino acid (N-terminus) on the left and 
the carbonyl of each amino acid on the right  The carbonyl on the last amino acid (C-
terminus) on the right side is most often an acid (designated as -OH, or amide (-NH2).   
 Substituents on amino acids with terminal amines on the side chains (such as lysine) 
are written in parentheses after the amino acid designation.  These are often a protecting 
groups such as Boc or Cbz, but in our case is a dye such as Cy5.5 or IR770Ti.  This 
nomenclature is illustrated below for the representative tetraproline imaging agent with an 
added d-alanine and lysines on both ends, one containing the dye Cy5.5, and the other 
containing the dye IR770Ti.   
(       )
 
Name:  Fmoc-Lys(Cy5.5)-dAla-Pro-Pro-Pro-Pro-Lys(IR770Ti)-NH2 
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Chapter 1. Background Information 
1a. Cancer and Early Detection 
Cancer is a group of diseases in which abnormal cells grow with the potential to 
invade and spread in the human body.1  If the spread is not controlled, it is likely to lead to 
death. Cancer can be caused by external factors including lack of physical activity, 
exposure to tobacco smoke, an unhealthy diet, or internal factors including hormones, 
genetic mutations, and immune conditions.1 Cancer is the second leading cause of death 
globally with over 8.8 million deaths reported in 2015.2 It is estimated that about 1.68 
million new cases of cancer will be diagnosed in the United States in 2017.1 It is urgent to 
find safe and effective treatments to fight cancer.  
The prognosis of patients with cancer mostly relies on the early detection of 
malignancy while still in the initial states of the disease.3 Current cancer screening tests 
such as computer tomography (CT), positron emission tomography (PET), magnetic 
resonance imaging (MRI), and Ultrasound (US) can help to detect cancer in the early stage, 
even before a person has symptoms.4 However, many cancer screening tests are inaccurate, 
and some can bring potential harm as well as benefits. For example, both false-positive and 
false-negative results are possible, which could lead to missed diagnosis, and repetition of 
screening procedures. The results of imprecise screening can lead to more costly screening 
tests, delays in cancer treatment and an increase in patient anxiety.4 Moreover, some 
screening procedures including biopsies can bring painful experiences like bleeding and 
infections.4 Clearly, a better method is needed for the early diagnosis of cancer to increase 
the likelihood of successful treatment and decrease morbidity and mortality.3  
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In order to obtain the greatest opportunity for early detection and treatment, a 
reliable cancer screening technique needs to be designed to fulfill several requirements. 
Firstly, this technique should be inexpensive to ensure widespread accessibility in primary 
care facilities including availability in developing nations across the world. Secondly, it 
should have high selectivity, high sensitivity, high resolution, and proven reliability. 
Thirdly, it should be able to guide biopsies for dependable testing results, thereby 
decreasing the number of biopsies during treatment, and to assist in active surveillance by 
measuring disease morphology and monitoring progression or reduction of disease. 
Fourthly, techniques such as CT (based on X-rays) and PET can lead to harmful side effects 
stemming from repetitive radiation. Ideally, a new screening method would make use of 
non-ionizing radiation.  
    
1b. Photoacoustic Imaging  
Photoacoustic imaging (PAI) has evolved in recent years as an extraordinarily 
useful functional imaging techniques with remarkable clinical potential.5-9 It provides a 
highly sensitive, non-ionizing, and non-invasive means of early detection for cancer.10,11 
Even though PAI is still in the preclinical stage, it is perceived globally as an outstanding 
new tool for cancer screening that will be more effective and more affordable than current 
screening instrumentation such as MRI and PET. Additionally, PAI is clean and green by 
virtue of using near infrared (NIR) light instead of ionizing radiation and fluorescent dyes 
versus iodinated, or heavy metal, contrast agents. It is found that PAI is specifically useful 
for tissues that are within 7 cm of the surface.  Recent studies have shown promising 
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development of PAI on several types of cancers such as prostate, breast, lymphoma, and 
thyroid cancer.10,11 
The mechanism of PAI is similar to US imaging (Figure 1). The photoacoustic 
signal is the result of an ultrasound wave produced by a nanosecond laser which radiates 
high frequency pulses of near infrared (NIR) light into a cell tissue at the frequency of 
ultrasound waves. Cancer cells can be detected and identified by PAI based on the ability 
to absorb light at two or more different wavelengths to measure differential concentrations 
of endogenous constituents in the tissues, such as deoxyhemoglobin (dHb) and oxy-
hemoglobin (HbO2). Different cells can thus have a measurable difference in the emitted 
ultrasound waves resulting from laser pulses at two wavelengths. The signals are collected 
independently by pulse sequencing and detected by US sensors, which create 2D and 3D 
images. Eventually the diseased tissue is able to be differentiated from healthy tissue by 
data analysis with subtraction algorithms. 
 
 
 
 
 
 
 
Figure 1. Illustration of acoustic wave generation for PAI. 
A recent example of a reliable and low-cost use of PAI imaging for prostate cancer 
screening is shown in Fig 2.12,13 This new multi-spectral PAI procedure was accomplished 
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in our research collaboration between the Rochester Institute of Technology (RIT) and the 
University of Rochester Medical Center (URMC). It was discovered that this new 
technique was able to differentiate malignant from benign prostate cancer by measuring 
changes in the relative concentrations of dHb and HbO2, where the concentration of dHb 
is elevated in the same location as the tumor as mapped by histological staining.  The 
signals from each compound were digitally computed and three dimensionally mapped 
using multi-spectral analysis. 
 
Figure 2.12,13 Multi-spectral PAI of prostate. (A) Prostate specimen (B) Histopathology 
of prostate with malignant region encircled. (C) Composite PA image at 760 nm (D) 
Composite PA image at 850 nm (E) absorption of dHb (F) absorption of HbO2.  
 
Even though pre-clinical testing of prostate resection slices demonstrates that PAI 
has higher specificity and sensitivity than transrectal ultrasound (TRUS), 13 the imaging 
depth of PAI is limited. In addition, the two endogenous chromophores dHb and HbO2 
used in PAI have small absorptivity factors (extinction coefficients), which result in weak 
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signals and allows only an imagining depth of 2 cm in tissue. Moreover, the endogenous 
chromophores have no specificity towards cancer cells and absorb in an overlapping 
wavelength range within other biological molecules, which makes it difficult to produce a 
high resolution image of the tumor cells for treatment. These factors restrict the use of PAI 
in in-vivo (animal) models. 
 
1c.  Near Infrared Fluorescent (NIRF) and Near Infrared Quencher (NIRQ) Dyes  
In order to solve the problem of comparatively shallow imaging depth, low 
absorption of light and poor image resolution, a dye system using exogenous chromophores 
have been designed to increase sensitivity relative to endogenous chromophores.8 It is 
recommended that the exogenous fluorescent (NIRF) dyes that absorb in the “biological 
NIR window” between 700-900 nm can impressively increase the US signal and image 
depth penetration for PAI.  
This optimal NIR window shown in Figure 3 is used as a guide to avoid the natural 
absorbance of Hb, HbO2, and H2O. It is optimal to choose NIR dyes in a range of absorption 
above 750 nm. Indocyanine dyes related to Indocyanine Green (ICG) such as Cy7, Alexa 
750, and IR800CW are ideal for this purpose, each giving an impressive improvement in 
sensitivity. One of the dyes, IR800CW, has been conjugated to a peptide that targets the 
neutropilin-1 receptor and was shown to be useful for the targeted PAI of breast cancer.14 
After excitation of cells by a laser, it was found that the PA signal from exogenous agents 
was two or three times higher than endogenous agents and the depth penetration of PAI for 
exogenous agents is also increased up to 7 cm.15 
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Figure 3. Biological imaging NIR window. 
In preliminary data arising from our collaboration with the team at the U of R, the 
absorption spectra for IR800CW was measured in our lab and plotted versus the 
photoacoustic (PA) spectra rom their lab as shown in Fig 4. The peak maxima were both 
normalized. The results indicate an excellent correlation between the wavelength of 
absorbed light and the wavelength of maximum photoacoustic signal.      
 
Figure 4. Overlay of absorption spectra (wavelength vs absorption) and PA spectra 
(wavelength vs. photoacoustic intensity) of IRdye800CW measured in our laboratories. 
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NIRF dyes have been widely used in cancer imaging, and their fluorescence 
properties have been optimized. As PAI is based on ultrasound waves, it is essential to 
recognize that sound produced from NIRF dyes alone is not optimal.  We speculate this is 
due to the energy lost as fluorescence.15 This idea is recently verified by the Gambhir 
group.15 They found out that a low wavelength (550 nm) quencher dye with relatively low 
molar absorptivity could produce a higher PA signal than NIRF dyes.15 This suggested to 
us that high wavelength, near-infrared quencher (NIRQ) dyes that do not fluoresce may 
yield superior photoacoustic signal than NIR dyes.  NIRQ dyes are structurally related to 
NIRF dyes but NIRQ dyes transfer the energy in a mechanism that inhibits, or quenches 
the fluorescence of itself or of a second dye after the absorption of light. The Jablonski 
diagram shown in Fig. 5 illustrates the mechanism of US generation for a NIRQ dye. The 
energy absorbed by the quencher is forced into excited states and released into non-
radiative relaxation to produces heat and the US waves. 
 
 
 
 
 
Figure 5.  Jablonski energy diagram. 
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Although quencher dyes have been employed for PAI,16 there has been no 
systematic study showing that they would be propitious for PAI.  Therefore, in order to 
examine the PAI signals for NIRQ dyes, our group purchased and synthesized a series of 
NIRF and NIRQ dyes, which even includes NIRQ dyes that have not been tested for PAI 
(Figure 6).  
 
Figure 6.  Vis-NIR spectroscopy of commercial NIRF dye (IRdye800CW) and NIRQ dye 
(QC-1) along with numerous related dyes synthesized in our lab including two lower 
absorbing quenchers.   
 
When they were tested by our collaborators at the U of R, it was discovered that 
NIRQ dyes alone, such as commercial QC1 and our synthesized Cy7.5AQ produced three 
times the PA signal than the NIRF dyes (Figure 7). It is especially notable that QC-1 has 
about one-third the absorbance of IR800cw, yet produces three times the sound.   
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Figure 7.  PAI spectroscopy of two NIRF dyes, IRdye800CW (Licor) and IR770Ti(our new 
replacement for IRdye800CW), exhibiting smaller peaks, and two quencher dyes, QC-1 
(Licor) and Cy7QAS showing three times the photoacoustic signal.    
 
This exciting result supports the hypothesis that if absorbance is suppressed, more 
energy will be converted to sound.  This led us to the further hypothesis that if a highly 
absorptive NIRF dye was used to capture the light, and used in tandem with a NIRQ dye 
that would quench its emission; this would provide an opportunity to synthesize a NIRF-
NIRQ dye pair system that would take advantage of the high absorptivity of NIRF dyes 
and the high signal produced by quenching by a NIRQ dye to yield a superior PAI signal.  
 
 
1d. FRET Effect with NIRF&NIRQ Dyes 
To test the hypothesis proposed above, a NIRF-NIRQ dye pair system was designed. 
We hypothesized that a NIRQ dye could be used to absorb the fluorescence of the first 
NIRF dye and quench the emission of light, thereby increasing the emission of sound by 
using Forster Resonance Energy Transfer (FRET) to convert all of the energy from light 
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absorption to PA signal.  The transfer of energy between two dye molecules, where 
emission of the second dye at a higher wavelength may be caused by absorption of light 
by the first dye, via the FRET effect, is illustrated in Fig 8a.   
There are two essential factors for generating FRET.  First, there must be spectral 
overlap between the donor and acceptor dye pair.  Secondly, the distance between the NIR 
dye pair, R0 must be optimized or placed in an acceptable range.  The equation involving 
distance is  EFRET = 1 /[1 + (R/R0)
6].  This distance is typically obtained by empirically by 
experimentation and varies in literature reports. Generally, it is not measured as a discrete 
value but is expressed as relatively large ranges, for example an estimation of between 20 
– 100 Angstroms.16    
The FRET effect may be used in two ways.  First, the fluorescence of a higher 
wavelength dye can be caused by irradiating a lower wavelength dye as shown in Fig 8a.  
The fluorescence of the lower wavelength dye can thus irradiate and activate the higher 
wavelength dye to induce it to fluoresce as shown in Fig 8b.   
The second manner in which FRET can be utilized is for quenching emission of 
light.  The may happen if the higher wavelength dye is a quencher dye, and here is good 
spectral overlap with the first dye.  In the mechanism of energy transfer leading to 
quenching, the energy by the absorbed by the second quencher dye in FRET, in turn, 
prevents fluorescence of the first dye. This process is shown in Fig 8c.   
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Figure 8. Mechanism for the use of FRET 8a) energy transfer between two dyes 8b) 
fluorescence of FRET 8c) quenching of FRET. 
 
In quenched system, the dye pair is considered as “dark dyes” with the higher 
wavelength dye known as a “dark quencher”.  In our theory, if the fluorescence is shut 
down during the absorption of the light in the paired-dye system, the wasted energy will 
be eliminated and provide generation of a better photoacoustic signal.   
The dark quencher systems are used in biological imaging studies, where the dyes 
are tethered together by a peptide, protein or other long chain in which an “active site” is 
used as a biomarker.  This active site is cleaved by the disease system releasing the 
separated dyes into solution resulting in fluorescence of the active NIRF dye component at 
the site of the diseased tissue. In the Gambhir approach, a metalloprotease, MMP, is used 
to derive diverse PA signal from the cleavage of the two NIRQ and NIRF dyes.15  
The optimal distance between FRET dye pairs in quenching has been studied by 
scientists at Licor.17-19  In several peptide systems they report an optimal distance of 
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between 40 and 60 Å for quenching.17  Moreover, examples of peptides that are 11-14 
amino acids in length were shown to offer an appropriate distance for quenching by FRET. 
17,18 
In our approach the spacer groups between dye pairs were designed to ensure 
proteolytic stability to retain quenching throughout the imaging procedure.  Furthermore, 
we will target specific cancer cell receptors by use of known biomarker targeting agents. 
Thus, by using NIRF dyes that have high extinction, and NIRQ dyes with broad quenching 
capacity with an appropriate spacer, we hypothesized the total energy will be converted to 
provide an optimal photoacoustic signal from the imaging agent.  
 
1e. Targeted Molecular Imaging Agents for Prostate Cancer  
For detecting specific types of cancer, targeted molecular imaging agents (TMIAs), 
can be designed by the conjugation of the imaging agent to targeting agents that specifically 
bind to cancer cells. TMIAs can greatly enhance the concentration of dyes at the site of 
cancer, which in turn strengthens the sensitivity of PAI signal.  In a modular synthetic 
approach developed in our lab, imaging agents which can be readily constructed are then 
conjugated to targeting groups in the last step.  By simply modifying or changing the 
targeting motif, the same imaging system can be conjugated to different targeting systems 
for different types of cancer.  Therefore, the FRET imaging system we developed for PAI 
has the potential to be applied to imaging a variety of cancers.  
The main goal in our lab is to develop targeted molecular imaging agents for 
prostate cancer (PCa).  In this case, prostate specific membrane antigen (PSMA) will be 
utilized as a target. PSMA is an enzyme that is over-expressed on the membrane of 
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aggressive PrCa cells, 20,21 but also existing at higher concentrations in other types of 
cancer.22 PSMA is an excellent biomarker for PrCa since the expression of PSMA is highly 
prominent in androgen-independent and metastatic PrCa disease but low on normal 
tissue.20-23 The near infrared dyes we use will be NIRF or NIRQ and pairs of NIRF-NIRQ 
dyes.  The two dyes will be synthesized and assembled on a peptide scaffold using a 
modular approach developed in our lab, and will be conjugated to a linker, then the PSMA 
targeting agent in the last step. 
Our overall experimental design focuses on synthesizing and testing NIRF and 
NIRQ dyes alone, then NIRF-NIRQ dye pairs for PAI and incorporating these systems into 
TMIAs. The over-arching goal is to use the methods we develop in this study and apply 
them to additional types of cancer by simply employing different targeting motifs, 
conjugated in the last step of the same approach.  Breast cancer (BrCa) is likely to be our 
next area of focus.  
With our collaborators, a new system was designed which combines new 
instrumentation for PAI with our innovative TMIAs to transform screening and diagnosis 
of PrCa. We have shown using both confocal fluorescence microscopy (CFM) and PAI 
that DCL, a urea that specifically binds to the PSMA receptor, can be conjugated to our 
modular NIRF dye system to provide effective TMIAs for PCa.    
By combining the advantages of targeting specific cancers by the methods we 
developed with the development of a FRET system, we envision a major advance in early 
screening and accurate diagnosis by PAI.  For prostate and breast cancer, our current focus, 
this will lead to a more sensitive means of imaging for accurate screening, guiding of 
biopsies, reduced number of biopsies, and monitoring of disease progression.  
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The strategy of combining the high absorptivity of a NIRF dye with suppression of 
fluorescence, which is wasted energy, by a NIRQ dye in a FRET system will result will be 
high-signal gain with dramatically increased sensitivity.  This will set the stage for 
discovering new, highly effective TMIAs for the specific imaging of cancer by PAI.  The 
targeted imaging methodology used in conjunction with our collaborators imaging 
technology will result in higher precision, more detailed images, affordable prices, and the 
availability of screening and diagnosis in primary care facilities including countries where 
expensive CT, MRI and PET imaging is not available. 
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Chapter 2. Synthetic Approach to High-gain NIR TMIA’s for PAI 
2a. Modular Approach Using “Puzzle Pieces” to Assemble TMIAs.  
The goal of this study is to develop methodology to synthesize a FRET dye pair 
system that could be used in any PAI application.  Our current application specifically 
focusses on the PAI of prostate cancer (PCa).  The most important aspect is to find the 
optimal distance between a NIRF and NIRQ dye pair.  Once this goal is achieved, the 
system could be utilized in the modular approach developed in our lab to synthesize the 
optimized FRET scaffold, and conjugate it to various targeting groups to produce FRET-
based TMIAs for PAI using a dual NIRF-NIRQ dye pair system.   
The first step to build up a new PAI dye system is to choose the appropriate NIRF 
and NIRQ dyes and “embed” them into amino acids (usually lysine) by the modular 
approach24.  In this process, the desired NIR dye is first attached to the side chain of lysine 
(Scheme 1) to form a “puzzle piece” by a coupling of the amine on the side chain of a 
lysine to a dye using standard peptide coupling reagents such as TSTU, TBTU, HATU and  
a non-reactive hindered amine base such as DIPA.  
NIR Dye
R = NH2 or OH
NIR Dye
Coupling with 
TSTU, TBTU or HATU
 
 
Scheme 1. The synthesis of a NIR dye “puzzle piece”. 
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The lysine module, or puzzle piece, is then incorporated into a TMIA by use of 
peptide synthesis methods shown in Scheme 2. The protecting group fluorenyl methylene 
oxy carbonyl (Fmoc) is first removed by a base (e.g. diethylamine), and the puzzle piece 
can be linked to another puzzle piece, or those puzzle pieces can be coupled to a linker, 
which provides the necessary spacer between targeting and imaging groups. The targeting 
group is added to the linker as the final step. Using this modular approach TMIAs can be 
constructed from NIR dyes and targeting agents that bind specifically to unique biomarkers 
for cancer cells.   
Base
R = NH
2
 or OH
 Coupling Linker 
NIR Dye
Coupling Targeting Group
LinkerLinker Targeting Agent
Linker
NIR Dye NIR Dye
Targeting Agent
NIR Dye
 
Scheme 2. Modular synthesis of a single dye TMIA. Step 1: removal of Fmoc protecting 
group from dye puzzle piece. Step 2: coupling of a linker to the lysine with the NIR dye on 
the side chain. Step 3: the targeting groups is conjugated to the other side of the linker. 
 
An example of our design using NIRF dye Cy5.5 is shown in Scheme 3.  The target 
TMIA shown is the Cy5.5 analog of YC-27 , a PSMA targeted TMIA synthesized by the 
Pomper group at Johns Hopkins where R=OH.25 The TMIA YC-27 is based on 
IRdye800cw, a Licor dye that absorbs at 770 nm and is used for in-vivo fluorescence, which  
works best within the NIR biological window.  The targeting urea and linker (DCL-DSS) 
is preferred since it was shown to strongly bind to the active site of PSMA, based on the 
studies at Johns  Hopkins25.                  
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In contrast to IR800CW, Cy5.5 absorbs at 680 nm and is ideal for in-vitro studies 
using confocal fluorescence microscopy (CFM), where the highest laser available is the 
Neon 630 laser.  In order for our collaborators in the Gosnell School of Life Science (SOLS) 
to test the targeting system in CFM one of our first goals was therefore to synthesize the 
TMIA based on Cy5.5.   
A tri-sulfonate version of the commercial tetra-sulfonated Cy5.5 was custom-made 
in our lab.  In order to ready the modular approach for application to this study,  the 
synthesis of a TMIA we termed “B-1” was optimized by the route illustrated in Scheme 3.   
This scheme is color-coded where the dye, Cy5.5, is blue, peptide scaffold is black, linker 
is purple and targeting agent, DCL, which targets the PSMA receptor, is red.   
Cy5.5 for PAI
DSS Linker
12
Peptide Coupling
DSS Linker
Cy5.5 for PAI
PCa Targeting
Agent DCL
PCa Targeting
Agent DCL
 
Scheme 3. An example of our modular approach used to synthesize TMIAs based on 
NIRF dye Cy5.5. The upper drawing illustrates the synthetic routine while the lower part 
is the structure of the final product synthesized in this study. 
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The binding of the TMIA “B-1”, to PCa cells was tested by students in the School 
of Life Sciences under the direction of our collaborator, Dr. Evans.  Prostate cancer (PCa) 
cells known to express PSMA (PSMA+) were treated with dilute solutions of B-1.  The 
results are shown in Figure 9. The targeted receptors are red while the cell nuclei are stained 
with a blue stain, strongly verifying a mechanism for targeting PrCa.  
 
 
Figure 9. CFM images of in vitro PSMA (+) PCa cells stained by the Cy5.5 TMIA. 
Theimaging agent B-1 in targeted receptors are red and the cell nuclei are blue.  
 
In early results the CFM studies showed that the uptake in cells appeared to be by 
the mechanism called endocytosis.  Endocytosis is a process where the dye first binds to a 
receptor in the membrane of the cell, then is engulfed, or drawn into the cell.  The process 
is repeated many times until the entire cell appears to be filled with TMIAs.  This result 
suggested that endocytosis may be an amplification mechanism for imaging PCa.   
Our success in the synthesis and the PSMA targeting method encouraged the 
pursuit of our hypothesis.  Our next goal was to test out other NIRF dyes, NIRQ dyes, and 
new NIRF-NIRQ dye pairs in the design of TMIAs for the PAI of PCa.    
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2b. Polyproline Ruler Approach to the FRET effect 
Our modular approach can also be employed to create molecular imaging agent 
systems using the FRET effect from a quencher-fluorescent dye pair. The two dyes could 
be placed on two different amino acids with a spacer peptide chain to separate them. 
However, the optimized distance between the two dyes has not yet been determined for 
FRET systems. Additionally, there are few reports providing information about how to 
establish spacers with the optimal FRET effects. 
In order to find the ideal distance between the two dyes, a “polyproline” spacer was 
designed. Polyproline is regarded as a rigid “molecular ruler” 26, where each proline is 
separated equally by an estimation of 3 angstrom as shown in Figure 10.27    
 
Figure 10. Various views for hexaproline. a) chemical structure b) crystal structure c) 
segmental side view d) view along the axis. 
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Because we expected to be able to synthesize various poly-prolines, and because 
others in our lab have synthesized NIRF and NIRQ dyes, we envisioned this approach as a 
useful route to find the optimal FRET distance in which we could apply our modular 
“puzzle piece” peptide methodology to synthesize the imaging peptides.  
Unfortunately, even if we were able to purchase the proline peptides and the dyes, 
it would be prohibitively expensive to carry out the synthesis. Even if these were affordable, 
due to the tiny amounts of dyes available (1-5 mg is $ 300 to $ 1000), it would be very 
difficult to carry out the chemistry on milligram to sub-milligram scales.   
It was therefore necessary to utilize dyes which have already been synthesized in 
ample quantity in our lab.  Our ultimate target would be the NIRF-NIRQ dye pair QC-1 
and IRdye800CW, both reported (and marketed) for FRET quenching by Licor.   
However, because both of these dyes have been difficult to synthesize we initially 
investigated the effect of distance between dyes using a non-quenched “dual-dye” FRET 
system which utilized two NIRF dyes synthesized in our lab: Cy5.5-3S and IR770TI.  The 
Cy5.5-3S is a tri-sulfonated analog of the commercial tetra-sulfonated Cy5.5, synthesized 
in our lab. The IR770Ti is a symmetrical analog of IRdye800CW also prepared in our lab.  
It is important to note that IRdye800CW is named for its fluorescence wavelength but has 
the same chromophore as IR770Ti, where 770 nm is the absorption maximum (lambda 
max) for both dyes.    
Peptide scaffolds were prepared by our modular method using the dye pair Cy5.5-
IR770Ti as designed in Scheme 4. The modular lysine-dye “puzzle pieces” were 
synthesized, and then joined with various polyproline spacers between them to prepare 
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“FRET imaging peptides” shown. The spectral overlap between the Cy5.5 and IR700Ti is 
shown in Fig. 11.28  The overlap is not large, but in studying similar overlapping dyes in 
the literature we felt it should be adequate to obtain a FRET effect for fluorescence of 
IR770Ti by irradiating at the optimal wavelength for Cy5.5.   
IR800CW NIRF Dye 
for FRET EM
Cy5.5 NIRF Dye 
for Exitation
Poly-proline spacer
n = 1,2,3
Poly-proline spacer
n = 1,2,3
Cy5.5 NIRF Dye 
for Exitation
IR800CW NIRF Dye 
for FRET EM
 
Scheme 4.  Synthesis of FRET model system for fluorescence dyes (first dye Cy5.5 is for 
excitation of FRET for second dye IRdye800CW.  
 
Figure 11. UV-Vis and fluorescence spectra for Cy5.5 and IRdye800CW from U of AZ 
interactive table.28 
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 Similar results were obtained by prior students in our lab by measuring our “home-
made” dyes and the commercial dye, QC-1. It is significant to notice that the UV absorption 
spectra in Figure 12 is not normalized, but was prepared using equimolar 4 µM 
concentration of dyes in each case.  It is apparent that the quencher (NIRQ) dye QC-1 can 
be seen to have considerably less absorption than the fluorescent (NIRF) dyes.  
 
Figure 12. UV-Vis-NIR and fluorescence spectrum for selected dyes synthesized and 
measured in our lab. 
 
The distance necessary for FRET is suggested by Licor to be 40-60 Angstroms.17,18 
In a detailed study also by Licor, quenching efficiency is reported to be 99 % between the 
dye pair QC-1 and IRdye800CW at a calculated distance of 29 Å.17 According to our 
estimates this would be equivalent to eight to twelve prolines plus the two lysines with side 
chain extensions. 
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  We needed to first develop the synthetic methods and therefore chose to begin 
with a diproline, then proceeded to tetra, then octa proline. If necessary, longer polyprolines 
could be made by the same approach in the future. Our goal was not necessarily to optimize, 
but to achieve a suitable distance for quenching by FRET.   
Because QC-1 has such a broad absorption (as shown in the figure 12 above, it 
has broad overlap with IRdye800CW, which helps the quenching efficiency immensely.18    
 
Figure 13. Comparison between absorption of QC-1 overlaid with fluorescence of 
IRdye800CW (right side of graph) shows complete spectral overlap. 18 
 
Di, tetra, and octaprolines were therefore synthesized by the dual protection 
strategy shown in Scheme 5. A protected monoproline was obtained from a commercial 
source as the starting material for all polyprolines.  The C-terminus of each proline building 
block was protected as a t-butyl ester, removable with trifluoroacetic acid (TFA).    
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The N terminus is protected by Fmoc, which is removed by a secondary amine (di-
ethyl amine).  The strategy shown in Scheme 5 below makes use of these two “orthogonally 
protecting groups” where the t-butyl ester is stable in the presence of a secondary amine, 
and the Fmoc group is stable in the presence of the acid, which is used to deprotect the 
Fmoc group. 
n=1,2,4, ..etc
n=1,2,4, ..etc
n=1,2,4, ..etc
n
n
n
Peptide Coupling
n=1,2,4, ..etc
Acid
Base
Scheme 5. Synthetic approach of polyproline. 
In order to prepare the dual dye imaging systems, two “puzzle pieces” Fmoc-
Lys(Cy5.5)-OH and Fmoc-Lys(IRdye800CW)-NH2 were synthesized as shown in 
Schemes 6 and 7 prior to insertion into the polyproline system above.  
DIPA
NMP
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Scheme 6. Synthesis of the Fmoc-Lys(Cy5.5)-OH module (puzzle piece).  
DIPA
NMP
 
Scheme 7. Synthesis of the Fmoc-Lys(IRdye800CW)-NH2 module (puzzle piece). 
Our collaborators have expressed a preference in PAI for higher wavelength dyes 
for use of a laser at about 770-850 nm.  For a non-FRET, single dye system the dye 
IRdye800CW could be used alone. But for a FRET quenching system, this requires the 
design of a quencher that absorbs light well above 800 nm.  For this purpose, the FRET-
quencher dye pair of IRdye800CW (NIRF dye) and QC1 (NIRQ dye) has been designed 
as shown in Scheme 8 below.   
To test the effect of distance on FRET, polyprolines comprised of the polypeptides 
from Scheme 5, were coupled to the modular lysine NIRF and/or NIRQ dye puzzle pieces 
in Schemes 6 and 7, to synthetize the polyproline dual dyes as shown in Scheme 8 below.    
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Peptide Coupling
IR800 NIRF Dye 
for Exitation
IR800 NIRF Dye 
for Exitation
Base
IR800 NIRF Dye 
for Exitation
Poly-proline spacer
n = 1,2,3
IR800 NIRF Dye 
for Exitation
Peptide Coupling
Poly-proline spacer
n = 1,2,3
Poly-proline spacer
n = 1,2,3
QC1 NIRQ Dye
for FRET Quenching
QC1 NIRQ Dye
for FRET Quenching
Poly-proline spacer
n = 1,2,3
 
Scheme 8. The application of optimized distance by polyproline in quencher system. 
 
The protecting group, Fmoc, is kept on the N-terminus of the FRET imaging 
peptide.  This is to enable completion of synthesis to the final TMIA in three steps:  a) 
deprotection of Fmoc, b) coupling of linker and c) conjugation of the targeting group.   
These final steps needed to be optimized so it may be accomplished in the future 
by our group – or any other group investigating similar imaging agents -  using the 
polyproline imaging peptide constructed with the optimal distance. 
 Initial testing to show the effective of the FRET system can be carried out on the 
non-targeted controls shown on in Scheme 8.  If each solution is the same concentration, 
signal strengths from the various FRET systems can be directly compared. This will save 
many synthetic steps versus testing the final TMIA for each separate polyproline.  
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2c. UV-Vis, Fluorescence and Photoacoustic Instrumentation for Our Designed Dye 
System 
The evaluation of the agents for FRET effect will be accomplished by UV-Vis 
absorption spectroscopy and fluorescence spectroscopy at RIT while the evaluation of 
agents for PAI will be finished through the new PAI instrumentation designed by Dr. Rao’s 
group at RIT and the University of Rochester as shown in Figure 14. 12, 13  This new 
instrumentation involves fast and high resolution PA images of ex-vivo tissue samples in a 
C-scan format acquired by a probe. The wavelength of this laser system is tunable and falls 
between the range from 700 to 1000 nanometers (nm) in the NIR.  An example of the 
photoacoustic spectroscopy available from this instrument is shown in Figure 4, Chapter 1. 
 
Figure 14. Acoustic lens based C-scan photoacoustic (PA) imaging device.  Near infrared 
laser illuminates the prostate tissue PA waves generated within the prostate will be focused 
by acoustic lens in real time onto the PA sensor to display PA images of the prostate.   
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Chapter 3. Result and Discussion 
3a. Instability of Fmoc-diproline Solved by Addition of Alanine to the Polyproline   
As the first synthetic step of a peptide spacer, the protected diproline, Fmoc-PP-
Otbu, (the one letter designation for proline is p,) was synthesized by a coupling reaction 
in Scheme 9, using TBTU and NMM as the coupling reagents, to yield the product as a 
white solid. However, a serious byproduct formed during purification and vacuum drying 
that was less soluble in most organic solvents and difficult to remove.  The byproduct had 
a MW 44 less than the desired product which is the mass of CO2 less.  We determined that 
the Fmoc protecting group was easily removed during isolation steps and fluorine 
byproduct from this step reacted with H-PP-Otbu to form a white impurity by the 
mechanism shown in Scheme 9 below.  
troublesome biproduct
CO2
1
TBTU, NNM
DCM
 
Scheme 9. Mechanism of the decomposition for Fmoc-Pro-Pro-Otbu. The white impurity 
was formed and did not dissolve in standard solvents such as DCM, ACN, and MeOH. 
 
The same phenomenon was observed after we synthesized the tetra proline which 
was similarly difficult to purify.  Furthermore, when we added a dye puzzle piece onto the 
di- and tetraprolines the loss in yield and purity due to the degradation of Fmoc on proline 
was a major setback in our approach as the dyes were very precious.   
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To solve this problem, we decided to add a d-alanine (d-Ala, in three letter 
designation, a, one letter designation in lower case for d-amino acids) group to each 
polyproline prior to the introduction of the precious dye puzzle pieces. We theorized this 
would prevent the formation of this impurity, which must be unique to the secondary cyclic 
amine in proline, while keeping the rigid distance critical to the design.   
The revised general synthetic routine is described in Scheme 10. The d-Ala is 
placed on the C-terminus of starting proline, diproline and tetraproline. Three new desired 
protected polyprolines including Fmoc-aPP-OH, Fmoc-aPPPP-OH, and Fmoc-
aPPPPPPPP-OH were successfully synthesized.  
 
n+m=2,3,4,etc
mn n+m
n+m=2,3,4,etc
Acid
Peptide Coupling
m=2,3,4, ..etcn=0,1,2,3,4 ..etc
n+m
 
 
Scheme 10. Synthetic methodology for the polyproline spacer with amino acid D-alanine. 
 
The details of the synthetic routes to the d-Ala diproline and d-Ala octaproline 
spacers are shown in Schemes 11-13. The tetraprolines were formulated from two 
diprolines, and the octaprolines were in turn formulated from two tetraprolines.  
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Scheme 11. Synthetic steps for Fmoc-dAla-Pro-Pro-OH,  4 
 
5
HATU, DIPA
6
DCM
7
8
9
20% TFA
1
HATU, DIPA
20% TFA
2
DCM
DCM
DCM
DCM
Scheme 12. Synthetic steps for Fmoc-dAla-Pro-Pro-Pro-Pro-OH 9 
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HATU, DIPA
10
DCM
11
20% TFA
9
7
DCM
 
Scheme 13. Synthetic steps for Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-OH 11 
       
While the initial design for Fmoc-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-OH was 
by the approach in Scheme 13, due to the low availability of our stored materials for Fmoc-
dAla-Pro-Pro-Pro-Pro-OH, 9 at the time, it was synthesized in a different way as shown in 
Scheme 14.   
As intermediate 6 was available, the t-butyl group was removed to form deprotected 
tetraproline intermediate 12, which was used to couple with intermediate 7 to form the 
protected octaproline as shown in Figure 14 below.  After cautious deprotection of Fmoc, 
working quickly with rapid purification to avoid major formation of byproduct, we were 
able to couple of d-alanine in the last step to produce the alanine-tetraproline by this 
alternative method. By either method, placement of the alanine before the introduction of 
the precious NIR dyes is an important aspect of our new alanine-polyproline design.  
However, the method in which D-ala is added early on, as in Scheme 12 above is clearly 
favorable.  
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Scheme 14. Alternate approach for Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-OH. 
 
3b. Improved Coupling Method for Prolines.  
The lower reactivity of secondary amines in peptide synthesis is known.  It was 
found that the H-PP-Otbu was less reactive in coupling with F-PP-OH. The initial attempt 
to synthesize Fmoc-PPPP-Otbu using TBTU and NMM only resulted in less than 10% 
yield. After trying various coupling reagents as described in table 1, we found activation 
with pivaloyl chloride and DIPA, an older peptide synthesis method, was the best coupling 
reagent to synthesize tetraproline, with an increase in yield of three times higher than our 
initial attempts.    
 
 
 
 
 
 33 
 
Table 1. Percent yield for the synthesis of tetraproline using different coupling reagents.   
2
5 Peptide Reagent
6
 
Peptide Reagents Yield 
TBTU, NMM <10% 
TSTU, NMM 12% 
pfp fail 
PyBop, DIPA fail 
Piv Cl, DIPA 42% 
 
3c. Precursor “puzzle pieces” for  the modular method for dual dye systems  
As described in Chapter 2, the dual dye approach we designed for FRET was based 
on construction of peptides by a modular method.  Modular amino acids, called “puzzle 
pieces” were thus synthesized and assembled as described in Schemes 2,3 and 8.  The 
puzzle pieces, in which lysines were attached to NIR dyes on their side chains, were 
coupled to polyproline spacers between them to construct the polyproline FRET peptides.   
In our initial design, we chose two NIRF dyes Cy5.5 and IRdye800CW for the dye 
pair. However, we faced some difficulties in the synthetic process and received a 
comparatively low yield in the synthesis of IR800dyeCW. So we decided to employ a 
replacement NIRF dye called IR770Ti, custom synthesized in our lab. The new dual dye 
pair system is shown above in Scheme 15 while the synthetic steps for the two puzzle 
pieces Cy5.5 and IR770TI is described above in Scheme 16 and 17.   
 34 
 
IR770Ti NIRF Dye
for FRET EM
Cy5.5 NIRF Dye 
for Exitation
Poly-proline spacer
n = 1,2,3
Poly-proline spacer
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Cy5.5 NIRF Dye 
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IR770Ti NIRF Dye
for FRET EM
 
 
Scheme 15. The proposed FRET effect dual dye system using NIRF dye Cy5.4 and NIRF 
dye IR770Ti. 
         
The synthesis of the Fmoc-Lys(Cy5.5)-NH2, or the Fmoc-Lys(Cy5.5)-OH is shown below 
in Scheme 16.  
R=OH or NH2
15
NMP
16
R=OH or NH2
R=OH or NH2
TSTU, DIPA
NMP
 
Scheme 16. Detailed synthetic steps for the Cy5.5 puzzle piece. 
 35 
 
The synthesis of the Fmoc-Lys(IR770Ti)-NH2, or Fmoc-Lys(IR770Ti)-OH is 
shown below in Scheme 17.  
18
R=OH, NH2
R=OH, NH2
NMP
17
TSTU, DIPA
DMF
R=OH, NH2
Scheme 17. Detailed synthetic steps for the IR770Ti puzzle piece 
3d. Solving the Problem of Instability with IR770Ti . 
As part of the synthetic strategy,  the synthesis and purification of IR770Ti puzzle 
piece was optimized. It became clear in our work that IR770Ti was fragile and not 
chemically stable in basic environments stemming from two observations. The first one 
was discovered during the purification step of the IR770Ti puzzle piece. The utilization of 
the HPLC solvent 0.01 M ammonium acetate buffer (pH=6.8) led to decomposition and 
low yield. The second was discovered during the reaction to remove the protecting Fmoc 
from the IR770Ti puzzle piece. The basic reagent diethylamine also lead to decomposition 
of the IR770Ti and a blue dye with wavelength λ = 650 nm was detected on the UV-Vis 
spectra as shown in the supplemental information. 
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Due to prior work on large Stoke’s shift dyes in our group, it was speculated that 
the decomposition resulted from displacement of the phenoxy group by the ammonia.  
Hence, a purification method for the IR770Ti puzzle piece was developed using an acidic 
0.01 M ammonium acetate buffer (pH4.7), which showed an increased yield to 80%.  
Prior to the addition of d-alanine, it was noticeable that the coupling between the 
second dye puzzle piece to the polyproline spacers was not successful due to the same 
reason as described in 3a.  Thus, during the synthesis considerable effort was applied to 
determine the coupling conditions for the second NIRF dye to the deprotected polyproline 
spacers.  
The coupling reagents HATU and DIPA were found to be the best coupling 
combination for the dye pair at this point. Additionally, during the purification step, the 
dye pair usually came out at almost the same retention time as the mysterious impurities 
produced during the coupling reaction.  
3e.  Development of modular method for dual dye systems on Polyproline Scaffolds.  
Upon solving the major synthesis problems described, it was possible to 
successfully synthesize the following modular polyproline dual dyes systems from the 
lysine “puzzle pieces and polyprolines described above:  
F-dK(IR770Ti)-PP-K(Cy5.5)-NH2  (21),   
F-dK(Cy5.5)-aPP-K(IR770Ti)-NH2 (24),  
F-dK(Cy5.5)-aPPPP-K(IR770Ti)-NH2  (27), 
Fmoc-dK(Cy5.5)-aPPPPPPPP-K(IR770Ti)-NH2 (30) as shown in Scheme 18-21. 
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Scheme 18. Synthetic steps for F-dK(IR770TI)-PP-K(Cy5.5)-NH2  21 
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The synthesis of the same diproline dual dye but with D-alanine attached is shown 
in Scheme 19.  The position of the dyes were reversed compared to Scheme 18.   
23
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15
22
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24
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Scheme 19. Synthetic steps for F-dK(Cy5.5)-aPP-K(IR770Ti)-NH2  24 
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Scheme 20. Synthetic steps for F-dK(Cy5.5)-aPPPP-K(IR770Ti)-NH2  27 
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Scheme 21. Synthetic steps for F-dK(Cy5.5)-aPPPPPPPP-K(IR770Ti)-NH2  30 
In the synthesis via Scheme 19-21 there were impurities close to the retention time 
in HPLC of the desired product reaquiring several attempts on a preparative HPLC to 
separate and obtain a comparatively pure product.  However, a better column (Phenomenex 
Synergi, which has a mixed phenyl and C6 stationary phase) was found to yield better 
separations and was used to isolate pure products.   
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3f.  UV-Vis and Fluorescence Spectroscopy of Di, Tetra and Octaproline  
Before testing the polyproline dual dyes synthesized above, we first measured the 
UV-Vis-NIR absorption and fluorescence spectra of the two NIRF puzzle pieces containing 
Cy5.5 (15) and IR770Ti (18).   These are shown in Figure 16, and are almost the same to 
the literature spectra and the spectra measured by students in our group with nearly 
identical λmax (Cy5.5 = 680 nm, IR770Ti = 773 nm).  The maximum fluorescent 
wavelengths were 793 nm in water and 796 nm in MeOH with a Stoke’s shift of about 30 
nm, as is well known or both cases.   
 
 
Figure 16. UV-Vis-NIR and Fluorescence Spectrum for F-dK(Cy5.5)-OH and H-
K(IR770Ti)-NH2 in different solvent conditions. (no dye aggregation was observed). 
 
When the polyproline dual-dyes containing Cy5.5 and IR770Ti were first analyzed, 
we used water as the solvent to measure absorption and fluorescence spectroscopy.  We 
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observed little or no FRET induced fluorescence of the second dye, IR770Ti.   However, 
we also observed unusual absorption spectroscopy behavior in pure water for the tetra- and 
octa proline dual-dyes as seen in Figure 17 and Figure 18 below.  We attribute this to dye 
aggregation.  This is apparently accentuated by the presence of poly-prolines in the 
molecule, which might be caused by accumulated hydrogen bonding from prolines.  When 
tested in 50, 80 % and 100% methanol, these aggregation effects were eliminated yielding 
the expected absorption spectra as shown in Scheme 17 below.  It is notable that in the 
aggregated state there would be little spectral overlap compared to the non-aggregated state.  
This is the likely cause for the low FRET effect in pure water.   
 
Figure 17. The effect of various methanol-water ratios for the NIR  spectrum for the dual 
dye tetraproline system: Fmoc-dK(Cy5.5)-dAla-Pro-Pro-Pro-Pro-K(IR770Ti)-NH2.   
The same aggregation behavior in water by the octaproline system, with similar 
return to the expected absorption spectra in 50 % water and pure water, is seen in Figure 
18.  The absorption spectra of a dilute mixture of the single dyes, Cy5.5 (λmax = 680 nm)  
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and IR770Ti 5 (λmax = 773 nm)  is also included in this graph for comparison.  It can be 
seen that the single dyes do not undergo the aggregation phenomena as the spectra do not 
shift in wavelength when the solvent is changed.  
 
Figure 18. The effect of various methanol-water ratios for the NIR  spectrum for the dual-
dye octaproline system: Fmoc-dK(Cy5.5)-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-
K(IR770Ti)-NH2. The green line is a sample of a dilute solution of a mixture of the single-
dyes,  F-dK(Cy5.5)-OH and H-K(IR770Ti)-NH2. 
 
 The initial fluorescence studies of tetraproline dual dyes show the unexpected effect 
of aggregation in water which leads to no FRET as shown in Figure 19 below.   In 
subsequent studies it was shown that when excited at 650 nm in water, there was no 
emission at 800 nm by the pure single dye IR770Ti, consistent with the result shown below.  
However, there was a tiny emission at 800 nm in pure methanol or methanol-water 
mixtures under these conditions (results shown in supplemental data).   It will be seen that 
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this tiny amount of emission, caused by absorption on the far left tail of IR770Ti does not 
account for the larger emission caused by FRET.     
 The fluorescence of the tetraproline dual dyes, Cy5.5 and IR770Ti, in water, upon 
excitation at various wavelengths is shown below with the expected maximum 
fluorescence resulting from excitation at λmax=680 nm.  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure19. The effect of various excitation wavelength on FRET shown by NIR fluorescence 
spectra for the dual dye tetraproline: Fmoc-dK(Cy5.5)-dAla-Pro-Pro-Pro-Pro-
K(IR770Ti)-NH2 in water. 
 
Because of the observations resulting from solvent effects on aggregation, we 
turned to looking for FRET in various ratios of methanol and water. When the tetraproline 
dye pair Cy5.5-IR700Ti was assayed, we were surprised to see a moderate but clearly 
observable FRET with fluorescence at 795 nm upon excitation at 680 nm (the λmax of 
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Cy5.5)  in methanol-water mixtures.  It was observed that pure methanol yielded the best 
result, as shown in Figure 20.  
 
Figure 20. The effect of various methanol-water ratios on FRET shown by NIR 
fluorescence spectra for the dual dye tetraproline: Fmoc-dK(Cy5.5)-dAla-Pro-Pro-Pro-
Pro-K(IR770Ti)-NH2 .  
 
 
 
 
 
The effect of excitation at various wavelengths for this system was tested next.  The 
maximum FRET was observed at 680 nm.  This is consistent with maximum absorption of 
Cy5.5 at 680 nm, as verified in Figure 21.   
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Figure 21. The effect of various excitation wavelength on FRET shown by NIR 
fluorescence spectra for the dual dye tetraproline: Fmoc-dK(Cy5.5)-dAla-Pro-Pro-Pro-
Pro-K(IR770Ti)-NH2 in MeOH (680 nm was verified as the optimal excitation wavelength). 
 
The FRET effect was likewise observed for the octaproline dual dye pair, but was 
much stronger than the tetraproline as seen in Figure 22.  This is consistent with the 
literature reports from Licor17,18 that 8-11 amino acids should be adequate for FRET 
between NIRF dyes with appropriate spectral overlap and distance R0.   The octaproline 
plus two lysines and an alanine in our FRET system is 11 amino acids.   
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Figure 22. The effect of various methanol-water ratios on FRET shown by NIR 
fluorescence spectra for the dual dye octaproline: Fmoc-dK(Cy5.5)-dAla-Pro-Pro-Pro-
Pro-Pro-Pro-Pro-Pro-K(IR770TI)-NH2   
 
The comparison between the diproline, tetraproline and octaproline dual dye 
system (Cy5.5 and IR770TI) is shown in Figure 23.   Upon excitation of the first dye at 
680 nm, the intensity of fluorescence from the second dye is observed to be twice as large 
for octaproline when normalized on the maximum emission of the first dye. However, the 
intensity of fluorescence in diproline dual dye system is very close to the tetraproline dual 
system, indicating the possibility that a shorter distance also leads to FRET effect.  
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Figure 23. Comparison of the FRET effect for di, tetra, and octaproline in MeOH 
 
These results provided tremendous encouragement that a similar system, designed 
with a NIRQ dye, such as quencher QC-1, should provide FRET quenching when paired 
with a NIRF dye, such as IR770Ti or IR800dyeCW as hypothesized in Chapter 2.  We can 
hypothesize this based on meeting a suitable, required distance between the two NIR dyes 
that we have determined and, from our own measurements in UV-Vis-NIR spectroscopy, 
there is large spectral overlap as shown in Figure 12.   
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Figure 24. Anomally fluorescence result for diproline dual dye system without addition of 
D-alanine.  
 
The anomaly fluorescence result for diproline dual dye system without addition of 
D-alanine was shown in Figure 24. It was surpised that this dual dye system could provide 
even stronger FRET effect than octaproline dual dye system with addition of D-alanine. 
There, our future study will determine whether the FRET effect is related to the additiona 
of D-alanine.  
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3g.  Application of Optimized FRET Distance to Quenching NIRF-NIRQ Systems  
Our ultimate goal was to find a system that provided FRET quenching.  From the 
NIRF-NIRF dual dye pairs, it is found that the octaproline could provide the best FRET 
fluorescent effect. Consequently, we decided to apply this distance to a NIRF-NIRQ dual 
dye system using IR770TI as the NIRF dye donor and QC1 as the NIRQ dye accepter. 
 Additionally, we decided to synthesize a tetraproline NIRF-NIRQ dye pair (for 
quenching) in order to compare the two prior NIRF-NIRF FRET systems and to verify that 
the octaproline would also have the best FRET quenching effect in our designed 
polyproline system.  
The QC1 “puzzle piece” Fmoc-dK(QC1)-OH was first synthesized as shown in 
Scheme 22.  
31
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Scheme 22. Synthesis of Fmoc-dK(QC1)-OH 
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The QC1 puzzle piece was then coupled to the previously synthesized tetraproline-
IR770Ti (the same tetraproline used for the NIRF-NIRF dye pair) to prepare Fmoc-
dLys(QC1)-dAla-Pro-Pro-Pro-Pro-Lys(IR770TI)-NH2 (32) using the same method 
developed in Chapter 3d as shown in Scheme 23, and Fmoc-dLys(QC1)-dAla-Pro-Pro-
Pro-Pro-Pro-Pro-Pro-Pro-Lys(IR770TI)-NH2 (33)  shown in scheme 24.  
31
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32
HATU, DIPA
 
Scheme 23. Synthesis of tetra quencher dual dye pair Fmoc-dk(QC1)-aPPPP-
K(IR770Ti)-NH2  
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This was followed by coupling the QC1 puzzle piece to the previously synthesized 
octaproline-IR770Ti (the same octaproline used for the NIRF-NIRF dye pair) to prepare 
Fmoc-dLys(QC1)-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Lys(IR770TI)-NH2 (33)  as 
shown in scheme 24.  
DMF
33
29
31
HATU, DIPA
 
 
Scheme 24. Synthesis of octa quencher dual dye Fmoc-dk(QC1)-aPPPPPPPP-
K(IR770Ti)-NH2 
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3h. Vis-NIR and Fluorescence for NIRF-NIRQ Dye Pair System. 
          In order to evaluate the FRET quenching in the NIRF-NIRQ dye pair system we 
prepared solutions of the tetra, and octaproline dual dyes and used the puzzle piece 
containing IR770Ti as a control. In order to ensure consistency in solutions of weak to 
strong optical density, solutions were prepared to achieve optical densities of 0.1, 0.25, 0.5, 
and 1.0 in Vis-NIR spectroscopy in methanol, water and a 1:1 mixture of these.  These are 
shown in Figures 25a, 25b,  26, and 27.  
        The absorption spectra for IR770Ti puzzle piece are shown in Figure 25a. Unlike the 
dual polyproline agents with NIRF-NIRF (Cy5.5 and IR770TI) dyes, the spectra in 
methanol versus water were nearly identical with no substantial difference.  This indicates 
little or no aggregation effects in the single dye species due to dilution factors.     
 
Figure 25a. UV-Vis spectrum of IR770Ti puzzle in different solvents with optical unity 
densities of 0.1, 0.25, 0.5, and 1.0.  
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To determine if the presence of polyproline could play a role in dye aggregation 
effects, solutions of the tetraproline with only one NIRF dye (IR770Ti) were also prepared 
at an optical unity density of 1 in water and methanol The absorption spectra for 
tetraproline with IR770Ti are shown contrasted with IR770Ti puzzle piece in Figure 24b. 
The spectra from both of these compounds were nearly identical in water and methanol, 
with little or no dye aggregation observed. Hence, the presence of polyproline with single 
NIRF dye had no effect on dye aggregation compared to the NIRF dye alone.   
 
Figure 25b. UV-Vis Spectra for H-K(IR77Ti0)-NH2 and Fmoc-aPPPP-K(IR770Ti)-NH2 
in Water and MeOH. Dye aggregation was not observed while only one dye (with or 
without polyproline) was present.  
 
        The absorption spectra for the tetraproline quencher dual NIRF-NIRQ dyes in 
methanol and water is shown in Figure 26. As above, all solutions were prepared to yield 
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optical density of 0.1, 0.25, 0.5, and 1.0. It is notable that the NIRF dye IR770TI has a 
much higher extinction coefficient than the NIRQ dye QC1 so that the absorption of 
IR770TI dominates in this dual dye system. As in the NIRF-NIRF dual dye system, the dye 
aggregation is again observed by the NIRF-NIRQ dye pair in water, leading to a 
hypsochromic shift of the maximum wavelength (λmax) from 773 nm to 730 nm. When 
compared to result of the single dye above (Figure 25b), it is clearly evident, and 
unexpected,  that this aggregation is heavily influenced by the presence of the polyproline 
when a second dye is also present.   
 
 
Figure 26. UV-Vis Spectrum of tetra quencher dual dye Fmoc-dK(QC1)-aPPPP-
K(IR770Ti)-NH2 in different solvents with Abs~0.1, 0.25, 0.5, 1. 
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The absorption spectra were then measured for octaproline quencher dual dye in 
methanol and water and the 1:1 mixture as shown in Figure 27. The solutions were likewise 
prepared at optical densities of 0.1, 0.25, 0.5, and 1.0. These spectra have similar results as 
in the tetraproline quencher dual dye system indicating substantial aggregation in water 
even at the lowest optical density where A = 0.1 when two dyes are linked by the 
polyproline.   
 
Figure 27. UV-Vis Spectrum of octa quencher dual dye Fmoc-dK(QC1)-aPPPPPPPP-
dK(IR770TI)-NH2 in different solvent with Abs~0.1, 0.25, 0.5, 1. 
 
Our original studies, including those with the NIRF-NIRF and NIRF-NIQ systems 
were conducted at an optical density 1.0. The first objective was to find the maximum 
excitation λ for the fluorescence, even if that fluorescence was residual quenching 
fluorescence. The fluorescence of the octaproline quencher dye pair was studied first 
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because it was expected to have the best FRET quenching result based on the results of the 
previous NIRF-NIRF dye pairs. The spectra for the octaproline NIRF-NIRQ dye pair with 
optical density of 1 in water at various excitation wavelengths are shown in Figure 28.  The 
wavelength of maximum excitation was found to be 765 nm.  
 
Figure 28. Fluorescence spectra of octa quencher dual dye Fmoc-dK(QC1)-
aPPPPPPPP-K(IR770Ti)-NH2 in water at various excitation wavelength. 
 
The fluorescence spectra of tetra- and octaproline NIRF-NIRQ dual dye systems at 
optical density 1 in water, methanol and 1:1 water-methanol are compared to the 
fluorescence spectra of the single dye IR770Ti puzzle piece in Figure 29 and 30.   
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Figure 29. Fluorescence spectra of tetra quencher dual dye Fmoc-dK(QC1)-aPPPP-
K(IR770Ti)-NH2 in various solvent at 765 nm. 
 
 
 
Figure 30. Fluorescence spectra of octa quencher dual dye Fmoc-dK(QC1)-
aPPPPPPPP-K(IR770Ti)-NH2 in various solvent at 765 nm (make lines thicker for 
second one). 
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Two amazing discoveries were observed as a result of two figures shown above.  
First, unlike in the NIRF-NIRF dye pair, the two NIRF-NIRQ dye pairs displayed FRET 
quenching - even in water. One potential explanation is that the two dyes (IR770TI and 
QC1) have a large spectral overlap even when the dye aggregation occurred in water.  This 
is due to the very broad absorption in the Vis-NIR spectrum of QC1 that encompasses the 
entire wavelength range of IR770TI as seen in Figures 6, 12 and 13 despite the shifts in 
UV-Vis-NIR absorption observed in water.     
The second discovery was that both tetra- and octaproline NIRF-NIRQ dual dye 
systems both displayed highly effective FRET quenching with the tetraproline dual dye 
pair quenching at one twentieth the magnitude of the fluorescence of IR770Ti and 
octaproline quencher dual dye quenching at one tenth of this fluorescence.     
In an attempt to compare the FRET quenching effect in tetra versus and octaproline 
NIRF-NIRQ dye pairs, the spectra above was magnified to better display the difference 
between the two quenched systems.   
 60 
 
 
Figure 31. A detailed fluorescence spectra for tetra and octa quencher dual dye in various 
solvent at 765 nm. 
As shown in Figure 31, it appears that the tetraproline had a stronger FRET 
quenching effect than octaproline dual dye system. However, both quenched fluorescence 
spectra were very small compared to fluorescence of  IR770TI itself, requiring considerable 
magnification which increases the error or variation of data. However, it was suggested to 
us that the inner filter could have an impact on the residual quenching fluorescence when 
the optical density is 1, which became our next concern. 
3i. The Effect of Solution Concentration in NIRF-NIRQ Dual Dye System.  
While our initial FRET studies were performed at an optical density of 1, to 
investigate the effect of concentration, including possible impacts from the inner filter 
effect, we extended our experiments to dilute solutions of the same NIRF-NIRQ dyes at 
optical densities of  0.1, 0.25,  0.5 and 1.0 for the octaproline quencher dye pair.   
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The results of the residual quenched fluorescence with optical density plotted 
versus fluorescence intensity are shown in Figure 32.  It is clear that impressive FRET 
quenching is occurring at all optical densities. However, the residual fluorescence did not 
increase by the same magnitude as increasing optical density.  Also, when the optical unity 
density approached 1, there appeared to be a slight decrease in fluorescence.  
 
Figure 32.. Effect of dilution effect of octa quencher dual dye Fmoc-dK(QC1)-
aPPPPPPPP-K(IR770Ti)-NH2 in various solvents at 765 nm. 
The significance of the deviation from the expected increase in signal strength with 
concentration is difficult to assess because the measurements are on a very small residual 
fluorescence left after quenching. These are very low in signal strength, near the limit of 
detection where signal noise is significant.   
The same fluorescence study was performed in tetraproline quencher dye as shown 
in Figure 33, demonstrating similar effects in the quenched octaproline system.   
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Figure 33. Inner filter effect of tetra quencher dual dye Fmoc-dK(QC1)-aPPPP-
K(IR770Ti)-NH2 in various solvents at 765 nm. 
 
With the uncertainty resulting from the low signals in figures 32 and 33, it was 
important to further verify that quenching by FRET occurs at lower concentrations than 
1.0.  The optical density of 0.1 is commonly used for fluorescence and quenching 
experiments to rule out inner filter effects.   Therefore, an additional set of studies at lower 
optical densities were conducted to ensure that the FRET quenching observed was due to 
the designed FRET system and not the other effects due to concentrations.     
 The fluorescence spectra of tetra- and octaproline NIRF-NIRQ dual dye systems 
in water, methanol and 1:1 water-methanol at the new optical density 0.1 are compared to 
the fluorescence spectra of the single dye IR770TI puzzle piece in Figure 34 and 35. 
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Figure 34. Fluorescence spectra of tetra quencher dual dye Fmoc-dK(QC1)-aPPPP-
K(IR770Ti)-NH2 in various solvent at 765 nm   
 
 
Figure 35. Fluorescence spectra of octa quencher dual dye Fmoc-dK(QC1)-aPPPPPPPP-
K(IR770Ti)-NH2 in various solvent at 765 nm  
0.00E+00
2.00E+05
4.00E+05
6.00E+05
8.00E+05
1.00E+06
1.20E+06
785 805 825 845 865 885
A
b
so
rb
an
ce
Wavelength (nm)
Fluorescence Spectra for Fmoc-dK(QC1)-aPPPP-K(IR770Ti)-NH2 vs. 
IR770 Puzzle Piece in Various Solvents (Abs= 0.1 Excites at 765 nm)
IR770 MeOH
IR770
50%MeOH
IR770 Water
Tetra MeOH
Tetra
50%MeOH
Tetra Water
0.00E+00
2.00E+05
4.00E+05
6.00E+05
8.00E+05
1.00E+06
1.20E+06
785 805 825 845 865 885
A
b
so
rb
an
ce
Wavelength (nm)
Fluorescence Spectra for Fmoc-dK(QC1)-aPPPPPPPP-K(IR770Ti)-
NH2 vs. IR770 Puzzle Piece in Various Solvents 
(Abs= 0.1 Ex at 765 nm)
IR770 MeOH
IR770
50%MeOH
IR770 Water
Octa MeOH
Octa
50%MeOH
 64 
 
Similar to the FRET quenching result from Figures 29, 30, and 31, the two NIRF-
NIRQ dye pairs still displayed FRET quenching effect when the optical density decreased 
from Abs=1 to Abs=0.1.  However, the magnitude of FRET quenching relative to 
fluorescence magnitude of IR770 puzzle piece had been decreased compared to the 
quenching at A=1. At optical density A= 0.1 both tetra- and octaproline NIRF-NIRQ 
systems quenched at one seventh the single NIRF dye in methanol. The tetraproline 
quenched at one fifth while octaproline quenched one eighth the magnitude in water.   
 To compare the FRET quenching effect in tetra versus and octaproline NIRF-NIRQ 
dye pairs at the lower optical density of 0.1, the spectra above was magnified to better 
display the difference between the two quenched systems as in Figure 36. It appears that 
octaproline had a stronger FRET quenching effect than tetraproline dual dye system, which 
is in contrast to our original study at optical density of 1 but this result was expected as in 
our hypothesis.  
As in the experiments comparing residual fluorescence versus optical density it is  
important to consider that at the optical density of 0.1 the signal from residual fluorescence 
is small and close to the limit of detection, where noise becomes a factor .  
Still, the quenched fluorescence resulting from the polyproline NIRF-NIRQ agents 
were very small to the unquenched fluorescence from IR770Ti puzzle piece itself. 
Moreover, the magnified fluorescence of tetraproline dual dye pair seemed to be interfered 
by background noise. Overall, the important finding was that both tetraproline and 
octaproline systems yielded highly effective FRET quenching capability.   
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Figure 36. A detailed fluorescence spectra for tetra and octa quencher dual dye in various 
solvent at 765 nm (Abs=0.1) 
 
The most surprising result for both 0.1 and 1.0 optical density solutions is that the 
tetraproline NIRF-NIRQ dye pair also appears to be a highly effective quencher system.  
This, in turn, points to the possibility that an even shorter distance may be possible to 
provide FRET quenching.  We are reminded, for example, of one literature reference 
indicating a distance of the large range from 20 to 100 Angstroms.  This finding indicates 
that it is important to synthesize and test the NIRF_NIRQ dual dye pair with even shorter 
distance like diproline as a first step in the future path for our research.   
Viewing the a previous anomaly in FRET in the NIRF-NIRF diproline, where the 
diproline with no d-Alanine had twice the FRET effect as the diproline with Alanine, this 
points to the need to synthesize both NIRF-NIRQ diprolines, one with d-Ala and one 
without, then evaluate them in FRET quenching experiments.  
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In a final phase of this research, these tetra and octaproline NIRF-NIRF dye pairs, 
and tetra and octaproline NIRF-NIRQ dye pairs from the syntheses above were selected 
for testing and submitted to collaborators at Roswell Park, and to collaborators at the 
University of Rochester for testing in PAI:   
F-dK(Cy5.5)-aPPPP-K(IR770TI)-NH2 
F-dK(Cy5.5)-aPPPPPPPP-K(IR770TI)-NH2 
Fmoc-dK(QC1)-aPPPP-K(IR770Ti)-NH2  
Fmoc-dK(QC1)-aPPPPPPPP-K(IR770Ti)-NH2 
We hope to learn of a large increase in the PA signal from this testing, but the results 
were still pending as of this publication.   
3j. Development of Synthetic Method for the TMIA, DCL-DSS-Lys(Cy5.5)-NH2 
In order to complete the methodology for the synthesis of the TMIAs from the 
polyproline - dye pair system, it was necessary to optimize three steps: deprotection of the 
imaging peptide, addition of a linker (DSS), and conjugation of the targeting urea (DCL) 
to the linker.   
We chose to optimize this methodology on a simpler system, the TMIA we termed 
“B-1”, (DCL-DSS-Lys(Cy5.5)-NH2). B-1 had been previously been synthesized, but in 
very low yield. During the course of this research, it was necessary to improve this 
synthesis as the imaging peptide precursors were now very precious.  Furthermore, we 
needed additional supplies of B-1, as our partnering Biology students needed additional 
material to study endocytosis, and verify this as an amplification mechanism.   
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The approach, shown in Scheme 25 was therefore optimized. The major 
improvement in this effort was the use of a heating bath at 40 degree Celsius to accelerate 
the reaction. Moreover, it was found that molecular sieves should be avoided the molecular 
sieves appeared to be involved in the reaction and caused the production of impurities. This 
developed method has increased the yield of final step from 5%  to 34 %.   
The optimization of these final three steps in the synthesis of the TMIA B-1 is 
directly applicable to other TMIAs prepared by the same modular (puzzle piece) method. 
This will include conjugation of linker and targeting group to the FRET imaging agents 
prepared in this study. As described in Chapter 2.b. the non-targeted dual dye polyproline 
FRET agents can be evaluated first, and then a TMIA created from the best candidate from 
the testing results from PAI could be synthesized and tested in vitro and in-vitro.   
15
NMM, DMF
35
16
DIPA, DMF
DEA, DMF
34
Scheme 25. Detailed synthetic steps for “B1”: DCL-DSS-Lys(Cy5.5)-NH2, 35 
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With B-1 available as a result of this study, our collaborators in SOLS were able to 
further study its uptake in PCa cells.  The endocytosis activity was confirmed by an 
eloquent series of imaging studies by CFM in which the influx of a DCL-targeted TMIA 
containing Cy5.5 was clearly shown to be co-localized with transferrin-FITC, an 
established marker for endocytosis, as seen in Figure 37.29   
 
 
 
 
 
 
 
 
Figure 37.29  CFM using B-1 validating that endocytosis occurs in PSMA+ cells. 
 
It is our hypothesis that the endocytosis mechanism will be an important means of 
amplifying ultrasound (US) signal in prostate cancer cells.  Endocytosis occurs when the 
interior of the cell engulfs the exogenous agent, and brings it into the cell.  The 
accumulation of TMIAs into the cytoplasm, in addition to the binding to the exterior cell 
membrane, should be a means of amplifying US signal just as evidenced by visibly 
amplifying fluorescence signal in confocal fluorescence microscopy . 
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Chapter 4. Conclusion  
To test the hypothesis that high-gain agents for PAI could be achieved from FRET 
quenching, peptide systems based on modular NIRF and NIRQ dye pairs separated by 
polyproline spacers were designed and synthesized. In order to find the optimized distance 
necessary for FRET, a synthetic method was developed to connect dye pairs of NIRF dyes 
(Cy5.5 and IR770Ti) separated by four polyproline spacers. Two of these were diprolines, 
one was a tetraproline, and one was octaproline.  These were assembled in a modular, 
puzzle-piece method, in which the NIRF dyes were conjugated to the side chain of lysines, 
then coupled to the both ends of the polyprolines.  
The dual-NIRF-NIRF agents were evaluated by UV-Vis-NIR and fluorescence 
spectroscopy in methanol and water solutions. It was observed that the tetra and octaproline 
spacers yielded solvent-dependent FRET induced fluorescence between NIRF-NIRF dye 
pairs with the octaproline, with the longest distance between dye pairs yielding the largest 
FRET effect.   
 This finding provided the evidence to apply the same approach to a FRET 
quenching system based on a NIRF-NIFQ dye pair (QC-1 and IR770Ti) resulting in the 
unexpected discovery that tetra and octaproline NIRF-NIRQ systems both yielded nearly 
complete FRET quenching.  The effect of dilution on the quenched dual dye systems was 
studied by measuring quenched fluorescence at optical densities ranging from 0.1 to 1.0.   
It was determined that the inner effect does not play a major role, and that FRET quenching 
was observed at all measured dilutions.   
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To complete the synthetic methodology for future synthesis of the targeted agents, 
the three final synthetic steps necessary to convert the polyproline dual dye agents into 
TMIAs were optimized through the synthesis of the single dye TMIA, DCL-DSS-
Lys(Cy5.5)-NH2, which is analogous to a known PSMA targeted imaging agent, YC-27.   
In our synthesis of polyprolines and new NIR dye pair systems, critical problems 
were solved, including decomposition of diprolines, low reactivity of secondary amine in 
polyproline coupling reactions, degradation of IR770Ti dye during synthesis, and 
purification of the final dual-dye products. To ensure high quality measurements, key 
intermediates and all products used in spectral measurements were purified by prep-HPLC 
and confirmed by Mass Spectroscopy (MS).   
The new dual dye polyproline system for FRET is an exciting advance in molecular 
imaging and will be a valuable tool for research aimed at providing higher signal and 
sensitivity in PAI.  The synthesis methodology is robust and reproducible.  By simply 
changing the targeting agent in the last step the synthesis of new TMIAs are now available 
from our modular dual-dye FRET methodology. The new FRET-TMIAs will be extremely 
useful for PAI system in both in-vivo and in-vitro cancer research, and ultimately, in 
detecting and diagnosing cancer in clinical patients.  
Samples of the NIRF-NIRF and NIRF-NIRQ dual dye polyprolines from this 
research have been submitted to collaborators for evaluation with PAI instrumentation at 
nearby cancer research centers with eager anticipation of the results.        
  
 71 
 
Chapter 5:  Experimental Procedures  
Materials and Methods 
 Chemicals were purchased from VWR, Aldrich, Alfa Aesar and TCI and were used 
as received unless otherwise stated. The HPLC instrument used for HPLC was an Agilent 
1100 with Diode Array Detector.  For LC-MS the instrument was a Waters 2695 Alliance 
HPLC with a Waters 2998 Diode Array Detector and an Agilent XDB C18 column, with 
dimensions of 3 mm by 100 mm or a Phenomenex Synergi column 5 mm by 100 mm and 
5 micron particle size.  The flow rate for HPLC was 0.5 mL/min with the mobile phase 
gradient starting at 80% solvent A (0.1 M ammonium acetate buffer) and 20% solvent B 
(acetonitrile or methanol) to 0% solvent A and 100% solvent B at 8 minutes, or from 20 % 
B to 80 % B.  For preparative HPLC the instrument was a Waters 600 pump with a Waters 
FCII Fraction Collector, utilizing a Dynamax C-18 83-241-C column, (dimensions), a 
Phenomenex Synergi Polar RP 270x21mm 10 µm column, and a Thermo Hypersil-
Keystone BDS C18 column. For some purifications, a 20 g C-18 Sep-pack (Varian Mega 
Bond Elut 20CC/5GRM)) SPE cartridge was utilized. The cartridge was conditioned with 
acetonitrile, then pure DI water then 5 % methanol, followed by loading the dissolved 
product and a step gradient of methanol 10-100 % in 5 % increments with 3-10 mL 
fractions each.  The UV-Vis spectrophotometer was a Shimadzu UV-2600, and the 
spectrofluorometer utilized was a Horiba Fluoromax-4 and fluorescence 
spectrophotometer.  Solutions were prepared to the concentrations necessary to yield the 
optical densities described in the results section.  The slit width setting for excitation was 
5 nm, and for emission was also 5 nm.  Common solvents and reagents used were 
dimethylformamide (DMF), n-methyl pyrolidone (NMP), n-methyl morpholine (NMM), 
and diisopropylethlamine (DIPA).  Common coupling agents of conventional use in 
peptide synthesis include TBTU, HATU and TSTU.   Common linkers include SMCC and 
DSS.  It should be noted that procedures on a scale less than 10 mg may incur substantial 
losses in yield from aliquots taken for LC-MS and other analyses. The dye Cy5.5 was 
synthesized in-house by a procedure related to cyanine dye labeling reagents.30 The dye 
IR770Ti was synthesized by a procedure related to the synthesis of IR800.31 QC-1 (5 mg) 
and IRdye800CW (5 mg) was a generous gift from LI-COR Biosciences.  
Synthetic Procedures 
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Fmoc-Pro-Pro-Otbu (1). Fmoc-L-proline (1000.0 mg, 2.96 mmol) was dissolved in DCM 
(40 mL), followed by the addition of NMM (899.5 mg, 8.89 mmol) and TBTU (1427.6 mg, 
4.45 mmol). A solution of L-proline tert-butyl ester (615.6 mg, 2.96 mmol) in DCM (40 
mL) was then added within 5 minutes. After being stirred at room temperature under Ar 
atmosphere for 1 hour, the reaction mixture was washed with 0.05M potassium bisulfate 
(2 × 50 mL), washed with distilled water (50 mL), dried over anhydrous magnesium sulfate, 
and filtered. The filtrate was evaporated at 35 °c under reduced pressure on a rotary 
evaporator.  Compound 1 was purified by column chromatography (silica gel, 10-100% 
ethyl acetate in hexane) and collected as a white solid (1.17 g. 80%): MS (ESI) m/z 491.48 
[M+H]+ (calcd. mass for C29H34N2O5: 490.246). UV/Vis (ACN): λmax = 264 nm. 
 
H-Pro-Pro-Otbu (2). Compound 1 (600.0 mg, 1.02 mmol) was dissolved in 
dichloromethane (10 mL), followed by the addition of diethylamine (745.4 mg, 10.2 mmol). 
After being stirred at room temperature for 2 hours, the resulting mixture was evaporated 
at 35 °c under reduced pressure on a rotary evaporator. Compound 2 was purified by high-
performance liquid chromatography (Thermo Hypersil-Keystone BDS C18 column, 10-80% 
MeOH in water) and collected as a yellow oil (141.9 mg, 52%): MS (ESI) m/z 269.31 
[M+H] +, (calcd. mass for C14H24N2O3: 268.17). 
  
Fmoc-dAla-Pro-Pro-Otbu (3). Fmoc-dAla-OH (480.0 mg, 1.46 mmol) was dissolved in 
DCM (30 mL), followed by addition of DIPA (1474.4 mg, 1.46 mmol) and HATU (676.1 
mg, 2.19 mmol). A solution of compound 2 (430.3 mg, 1.60 mmol) in dichloromethane (30 
mL) was then added within 20 minutes. After being stirred at room temperature under Ar 
atmosphere for 1 hour, the resulting mixture was washed with 0.05M potassium bisulfate 
(2 × 40 mL), washed with distilled water (40 mL), dried over anhydrous magnesium sulfate, 
and filtered. The filtrate was evaporated at 35 °c under reduced pressure on a rotary 
evaporator. Compound 3 was purified by column chromatography (silica gel, 30-100% 
ethyl acetate in hexane) and collected as a white solid (519.6 mg. 64%): MS (ESI) m/z 
562.54 [M+H]+, HRMS (m/z) 562.2921 [M+H]+, (calcd. mass for C32H39N3O6: 561.28389). 
UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-ala-Pro-Pro-OH (4). Compound 3 (519.6 mg, 0.925 mmol) was added to a solution 
of TFA/DCM (1:5, 10 mL). The resulting mixture was stirred for 2 hours at room 
temperature. After evaporation of the solvent in-vacuo, the crude pale yellow solid 4 was 
obtained. The crude 4 was used without further purification. MS (ESI) m/z 506.41 [M+H]+,  
(calcd. mass for C28H31N3O6: 505.56). UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-Pro-Pro-OH (5).  Compound 1 (800.0 mg, 1.63 mmol) was added to a solution of 
TFA/DCM (1:5, 10 mL). The resulting mixture was stirred for 2 hours at room temperature. 
After evaporation of the solvent in- vacuo, the crude pale yellow solid 5 was obtained. The 
crude 5 was used without further purification. MS (ESI) m/z 435.32 [M+H]+,  (calcd. mass 
for C25H26N2O5: 434.18). UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-Pro-Pro-Pro-Pro-Otbu (6). Compound 5 (1220.0 mg, 2.81 mmol) was dissolved 
in THF (20 mL), followed by the addition of NMM (1136.1 mg, 11.2 mmol) and pivaloyl 
chloride (406.3 mg, 3.37 mmol). After the mixture was stirred at 0 °C under Ar atmosphere 
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for 30 minutes, a solution of compound 2 (828.9 mg, 3.09 mmol) in THF (20 mL) was 
added. Then the resulting mixture was stirred at room temperature under Ar atmosphere 
for 2 hours. Within the addition of ethyl acetate (50 mL), the reaction mixture was washed 
with 0.05M potassium bisulfate (2 × 50 mL), washed with distilled water (50 mL), dried 
over anhydrous magnesium sulfate, and filtered. The filtrate was evaporated at 35 °c under 
reduced pressure on a rotary evaporator.  After purification by column chromatography 
(silica gel, 1-10% methanol in ethyl acetate), compound 6 was collected as a white solid 
(800.0 mg. 42%): MS (ESI) m/z 685.65 [M+H]+, HRMS (m/z) 685.3599 [M+H]+, (calcd. 
mass for C39H48N4O7: 684.3523). UV/Vis (ACN): λmax = 264 nm. 
 
H-Pro-Pro-Pro-Pro-Otbu (7). Compound 6 (323.0 mg, 0.472 mmol) was dissolved in 
dichloromethane (10 mL), followed by the addition of diethylamine (345.2 mg, 4.72 mmol). 
After being stirred at room temperature for 2 hours, the resulting mixture was evaporated 
at 35 °c under reduced pressure on a rotary evaporator. Compound 7 was purified by high-
performance liquid chromatography (Keystore Scientific Hyperprep BDS C18 column, 10-
80% MeOH in water) and collected as a yellow oil (101.3 mg, 46%): MS (ESI) m/z 463.51 
[M+H]+, (calcd. mass for C24H38N4O5 462.28). 
 
Fmoc-dAla-Pro-Pro-Pro-Pro-Otbu (8). Fmoc-dAla-OH (62.0 mg, 0.199 mmol) was 
dissolved in dichloromethane (10 mL), followed by the addition of DIPA (386.1 mg, 2.99 
mmol) and HATU (113.6 mg, 0.299 mmol). Then, a solution of compound 7 (101.3 mg, 
0.219 mmol) in dichloromethane (10 mL) was added within 20 minutes.  After being stirred 
at room temperature under Ar atmosphere for 2 hours, the resulting mixture was washed 
with 0.05M potassium bisulfate (2 × 20 mL), washed with distilled water (20 mL), dried 
over anhydrous magnesium sulfate, and filtered. The filtrate was evaporated at 35 °c under 
reduced pressure on a rotary evaporator. Compound 8 was purified by column 
chromatography (silica gel, 1-10% methanol in ethyl acetate) and collected as a white solid 
(111.9 mg. 74%): MS (ESI) m/z 773.66 [M+H2O]
+, HRMS (m/z) 756.3961 [M+H]+,  
(calcd. mass for C42H53N5O8: 755.38941). UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-ala-Pro-Pro-Pro-Pro-OH (9). Compound 8 (111.9 mg, 0.148 mmol) was added to 
a solution of TFA/DCM (1:5, 10 mL). The resulting mixture was stirred for 3 hours at room 
temperature. After evaporation of the solvent in-vacuo, the crude pale yellow solid 9 was 
obtained. The crude 9 was used without further purification. MS (ESI) m/z 700.59 [M+H]+,  
(calcd. mass for C38H45N5O8: 699.33). UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Otbu (10). Fmoc-dAla-OH (49.0 mg, 
0.158 mmol) was dissolved in dichloromethane (10 mL), followed by the addition of DIPA 
(203.6 mg, 1.58 mmol) and HATU (89.8 mg, 0.236 mmol). Then, a solution of compound 
14 (134.0 mg, 0.158 mmol) in dichloromethane (10 mL) was added within 20 minutes.  
After being stirred at room temperature under Ar atmosphere for 2 hours, the resulting 
mixture was washed with 0.05M potassium bisulfate (2 × 20 mL), washed with distilled 
water (20 mL), dried over anhydrous magnesium sulfate, and filtered. The filtrate was 
evaporated at 35 °c under reduced pressure on a rotary evaporator. Compound 10 was 
purified by solid phase extraction (10-100% acetonitrile in water) and yield as white solid 
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(36.0 mg. 20%): MS (ESI) m/z 1162.08 [M+H2O]
+, HRMS (m/z) 1144.6064 [M+H]+,  
(calcd. mass for C62H81N9O12: 1143.60067). UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-OH (11). Compound 10 (18.2 mg, 0.0159 
mmol) was added to a solution of TFA/DCM (1:5, 10 mL). The resulting mixture was 
stirred for 3 hours at room temperature. After evaporation of the solvent in-vacuo, the crude 
pale yellow solid 11 was obtained. The crude 11 was used without further purification. MS 
(ESI) m/z 1089.07 [M+H]+,  (calcd. mass for C58H73N9O12: 1087.54). UV/Vis (ACN): λmax 
= 264 nm. 
 
Fmoc-Pro-Pro-Pro-Pro-OH (12). Compound 6 (220.0 mg, 0.321 mmol) was added to a 
solution of TFA/DCM (1:5, 10 mL). The resulting mixture was stirred for 2 hours at room 
temperature. After evaporation of the solvent in- vacuo, the crude pale yellow solid 12 was 
obtained. The crude 12 was used without further purification. MS (ESI) m/z 629.64 
[M+H]+,  (calcd. mass for C35H40N4O7: 628.28). UV/Vis (ACN): λmax = 264 nm. 
 
Fmoc-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Otbu (13). Compound 12 (100.0 mg, 0.159 
mmol) was dissolved in dichloromethane (10 mL), followed by the addition of DIPA 
(205.7 mg, 1.59 mmol) and HATU (90.8 mg, 0.239 mmol). Then, a solution of compound 
7 (73.6 mg, 0.159 mmol) in dichloromethane (10 mL) was added within 20 minutes.  After 
being stirred at room temperature under Ar atmosphere for 2 hour, the resulting mixture 
was washed with 0.05M potassium bisulfate (2 × 10 mL), washed with distilled water (10 
mL), dried over anhydrous magnesium sulfate, and filtered. The filtrate was evaporated at 
35 °c under reduced pressure on a rotary evaporator. The crude product 13 was yield as a 
pale yellow solid and used without further purification: MS (ESI) m/z 1090.86 [M+H2O]
+, 
(calcd. mass for C59H76N8O11: 1072.56). UV/Vis (ACN): λmax = 264 nm. 
 
H-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Otbu (14). Compound 13 (170.0 mg, 0.158 mmol) 
was dissolved in dichloromethane (10 mL), followed by the addition of diethylamine (58.0 
mg, 0.792 mmol). After being stirred at room temperature for 3 hours, the resulting mixture 
was evaporated at 35 °c under reduced pressure on a rotary evaporator. The crude product 
14 was collected as a yellow oil and used without further purification: MS (ESI) m/z 851.72 
[M+H]+, (calcd. mass for C44H66N8O9: 850.49). 
 
Fmoc-dK(Cy55)-OH (15). General Procedure: 1 equivalent of Fmoc-dK(H)-OH or Fmoc-
K(H)-NH2 was dissolved in NMP (2 mL), followed by the addition of 10 equivalents of 
DIPA and 1 equivalent of Cy5.5-NHS ester. After being stirred at room temperature under 
Ar atmosphere for 20 minutes, the resulting mixture was treated with ether, centrifuged 
down, and dried in vacuum. The crude product 15 was yield as a blue solid and used 
without further purification. MS (ESI) m/z 606.52 [(M-2H)/2]-, (calcd. mss for 
C64H70O14S3: 1214.405). UV/Vis (MeOH): λmax = 680 nm. For R=NH2 was prepared by 
Ryan in our lab.  
 
H-dK(Cy55)-NH2 (16). Compound 15 (6.0 mg, 4.94 E-3 mmol) was dissolved in NMP (3 
mL), followed by the addition of diethylamine (7.23 mg, 0.0988 mmol). After being stirred 
at room temperature for 2 hours, the resulting mixture was precipitated with ether, washed 
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with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and freeze-dried. The crude 
product 14 was collected as a blue solid and used without further purification: MS (ESI) 
m/z 990.73 [M-H]-, 494.86 [(M-2H)/2]-, (calcd. mass for C49H61N5O11S3: 991.35). UV/Vis 
(MeOH): λmax = 680 nm. 
 
Fmoc-K(IR770)- NH2 (17a). General Procedure: 1 equivalent of Fmoc-K(H)-NH2 was 
dissolved in NMP (2 mL), followed by the addition of 5 equivalents of DIPA. and 1 
equivalent of IR770-NHS ester. After being stirred at room temperature under Ar 
atmosphere for 20 minutes, the resulting mixture was treated with ether, centrifuged down, 
and dried in vacuum. Compound 17 was purified by high-performance liquid 
chromatography (Rainin Dynamax C18 83-241-C column, 10-60% methanol in 0.01M 
ammonium acetate, pH=4.7) and collected as a green solid. For R=NH2 (80% yield), MS 
(ESI) m/z 682.05 [(M-2H)/2]-, 454.39 [(M-3H)/3]-, HRMS (m/z) 454.1362 [(M-3H)/3]-, 
681.7098 [(M-2H)/2]-, (calcd. mass for C68H79N5O17S4: 1365.43538). UV/Vis (MeOH): 
λmax = 775 nm.  
 
Fmoc-dK(IR770)-OH (17b). Prepared by the procedure of 17a.  For R=OH, it was made 
from impure starting material thus no percentage yield was given. MS (ESI) m/z 454.85 
[(M-3H)/3]-, 682.54 [(M-2H)/2]-, HRMS (m/z) 454.4639 [(M-3H)/3]-, 682.2018 [(M-
2H)/2]-, 1365.4131 [M-H]-, (calcd. mass for C68H78N4O18S4: 1366.41939). UV/Vis (MeOH): 
λmax = 775 nm. 
 
H-K(IR770)-NH2 (18). Compound 17 (30.0 mg, 0.022 mmol) was dissolved in DMF (4 
mL), followed by the addition of diethylamine (8.05 mg, 0.11 mmol). After being stirred 
at room temperature for 2 hours, the resulting mixture was precipitated with ether, washed 
with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and freeze-dried. The crude 
product 14 was collected as a green solid and used without further purification: MS (ESI) 
m/z 570.96 [(M-2H)/2]-,  (calcd. mass for C53H69N5O15S4: 1143.37). UV/Vis (MeOH): λmax 
= 773 nm. 
 
Fmoc-Pro-Pro-K(Cy55)-NH2 (19). Compound 5 (7.5 mg, 0.0173 mmol) was dissolved in 
DMF (3 mL), followed by the addition of NMM (10.4 mg, 0.104 mmol) and TBTU (8.3 
mg, 0.0259 mmol). Then, a solution of compound 16 (17.1 mg, 0.0173 mmol) in DMF (3 
mL) was added within 30 minutes.  After being stirred at room temperature under Ar 
atmosphere for 5 hours, the resulting mixture was precipitated with ether, washed with 1:1 
ether/ethyl acetate (2 × 10 mL), centrifuged down, and dried in vacuum. Compound 19 
was purified by high-performance liquid chromatography (Thermo Hypersil-Keystone 
BDS C18 column, 40-70% methanol in water) and collected as a blue solid (15.8 mg, 65%): 
MS (ESI) m/z 703.01 [(M-2H)/2]-, HRMS (m/z) 702.7555 [(M-2H)/2]-, (calcd. mass for 
C74H85N7O15S3: 1407.52658). UV/Vis (MeOH): λmax = 682 nm. 
 
H-Pro-Pro-K(Cy55)-NH2 (20). Compound 19 (15.8 mg, 0.0112 mmol) was dissolved in 
DMF (2 mL), followed by the addition of diethylamine (8.2 mg, 0.112 mmol). After being 
stirred at room temperature for 2 hours, the resulting mixture was precipitated with ether, 
washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and freeze-dried. The 
crude product 20 was collected as a blue solid and used without further purification: MS 
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(ESI) m/z 592.20 [(M-2H)/2]-, HRMS (m/z) 1186.4631[M+H]+, 593.7371 [(M+2H)/2]+,  
(calcd. mass for C59H75N7O13S3: 1185.4585). UV/Vis (MeOH): λmax = 682 nm. 
 
Fmoc-dK(IR770)-Pro-Pro-K(Cy55)-NH2 (21). Compound 17 (10.0 mg, 7.33E-3 mmol) 
was dissolved in DMF (2 mL), followed by the addition of DIPA (9.47 mg, 0.0733 mmol) 
and HATU (4.18 mg, 0.011 mmol). Then, a solution of compound 20 (8.69 mg, 7.33E-3 
mmol) in DMF (2 mL) was added within 20 minutes.  After being stirred at room 
temperature under Ar atmosphere for 3 hours, the resulting mixture was precipitated with 
ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and dried in 
vacuum. Compound 21 was purified by high-performance liquid chromatography (Rainin 
Dynamax C18 83-241-C column, 5-30% ACN in 0.02 M ammonium acetate buffer, 
pH=4.7) and collected as a green-blue solid (2.6 mg, 14%): MS (ESI) m/z 844.12 [(M-
3H)/3]-, HRMS (m/z) 843.6133 [(M-3H)/3]-, 1265.9265 [(M-2H)/2]-, (calcd. mass for 
C127H151N11O30S7 :2533.86733). UV/Vis (MeOH): λmax = 682, 777 nm. 
 
Fmoc-dAla-Pro-Pro-K(IR770)-NH2 (22).  Compound 4 (4.0 mg, 7.91E-3 mmol) was 
dissolved in DMF (2 mL), followed by the addition of DIPA (20.5 mg, 0.158 mmol) and 
TSTU (4.8 mg, 0.0158 mmol). Then, a solution of compound 18 (9.9 mg, 8.70 E-3 mmol) 
in DMF (2 mL) was added within 30 minutes.  After being stirred at room temperature 
under Ar atmosphere for overnight, the resulting mixture was precipitated with ether, 
washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and dried in vacuum. 
Compound 22 was purified by high-performance liquid chromatography (Rainin Dynamax 
C18 83-241-C column, 10-60% methanol in 0.01 M ammonium acetate buffer, pH=4.7) 
and collected as a green solid (6.0 mg, 47%): MS (ESI) m/z 542.74 [(M-3H)/3]-, 
814.83[(M-2H)/2]-,(calcd. mass for C81H98N8O20S4: 1630.58). UV/Vis (MeOH): λmax = 
775 nm. 
 
H-dAla-Pro-Pro-K(IR770)-NH2 (23). Compound 22 (6.0 mg, 3.69E-3 mmol) was 
dissolved in DMF (2 mL), followed by the addition of diethylamine (1.35 mg, 0.018 mmol). 
After being stirred at room temperature for 3 hours, the resulting mixture was precipitated 
with ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and freeze-
dried. The crude product 23 was collected as a green solid and used without further 
purification: MS (ESI) m/z 703.48[(M-2H)/2]-, (calcd. mass for C66H88N8O18S4: 1408.51). 
UV/Vis (MeOH): λmax = 775 nm. 
 
Fmoc-dK(Cy55)-dAla-Pro-Pro-K(IR770)-NH2 (24). Compound 15 (4.5 mg, 3.71E-3 
mmol) was dissolved in DMF (2 mL), followed by the addition of DIPA (4.79 mg, 0.037 
mmol) and HATU (2.11 mg, 5.56E-3 mmol). Then, a solution of compound 23 (5.21 mg, 
3.71 E-3 mmol) in DMF (2 mL) was added within 20 minutes.  After being stirred at room 
temperature under Ar atmosphere for overnight, the resulting mixture was precipitated with 
ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and dried in 
vacuum. Compound 24 was purified by high-performance liquid chromatography (Rainin 
Dynamax C18 83-241-C column, 10-60% methanol in 0.01 M ammonium acetate buffer, 
pH=4.7) and collected as a green-blue solid (3.3 mg, 34%): MS (ESI) m/z 867.97 [(M-
3H)/3]-, 1302.89 [(M-2H)/2]-, HRMS (m/z) 867.2925 [(M-3H)/3]-, 1301.4468 [(M-2H)/2]-, 
(calcd. mass for C130H156N12O31S7: 2604.90444). UV/Vis (MeOH): λmax = 683, 775 nm. 
 77 
 
 
Fmoc-dAla-Pro-Pro-Pro-Pro-K(IR770)-NH2 (25).  Compound 9 (8.0 mg, 0.0114 mmol) 
was dissolved in DMF (2 mL), followed by the addition of DIPA (14.8 mg, 0.114 mmol) 
and HATU (8.7 mg, 0.0229 mmol). Then, a solution of compound 18 (13.1 mg, 0.0114 
mmol) in DMF (2 mL) was added within 30 minutes.  After being stirred at room 
temperature under Ar atmosphere for overnight, the resulting mixture was precipitated with 
ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and dried in 
vacuum. The crude product 25 was yield as a green solid and used without further 
purification: MS (ESI) m/z 608.13 [(M-3H)/3]-, 911.55 [(M-2H)/2]-,(calcd. mass for 
C91H112N10O22S4: 1824.68). UV/Vis (MeOH): λmax = 770 nm. 
 
 
H-dAla-Pro-Pro-Pro-Pro-K(IR770)-NH2 (26). Compound 25 (20.8 mg, 0.0114 mmol) 
was dissolved in DMF (4 mL), followed by the addition of diethylamine (4.17 mg, 0.057 
mmol). After being stirred at room temperature for 90 minutes, the resulting mixture was 
precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, 
and freeze-dried. The crude product 26 was collected as a green solid and used without 
further purification: MS (ESI) m/z 802.81 [(M+2H)/2]+,(calcd. mass for C76H102N10O20S4: 
1602.62). UV/Vis (MeOH): λmax = 773 nm. 
 
 
Fmoc-dK(Cy55)-dAla-Pro-Pro-Pro-Pro-K(IR770)-NH2 (27). Compound 15 (14.0 mg, 
0.0115 mmol) was dissolved in DMF (2 mL), followed by the addition of DIPA (14.9 mg, 
0.115 mmol) and HATU (6.58 mg, 0.0173 mmol). Then, a solution of compound 26 (18.27 
mg, 0.0114 mmol) in DMF (2 mL) was added within 20 minutes.  After being stirred at 
room temperature under Ar atmosphere for 105 minutes, the resulting mixture was 
precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, 
and dried in vacuum. Compound 27 was purified by high-performance liquid 
chromatography (Rainin Dynamax C18 83-241-C column, 5-30% methanol in 0.01 M 
ammonium acetate buffer, pH=4.7) and collected as a green-blue solid (1.6 mg, 5%): MS 
(ESI) m/z 699.28[(M-4H)/4]-, 932.61 [(M-3H)/3]-, HRMS (m/z) 931.9936 [(M-3H)/3]-, 
(calcd. mass for C140H170N14O33S7: 2801.02562). UV/Vis (MeOH): λmax = 685, 773 nm. 
 
Fmoc-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-K(IR770)-NH2 (28). Compound 11 
(15.0 mg, 0.0138 mmol) was dissolved in DMF (2 mL), followed by the addition of DIPA 
(17.8 mg, 0.138 mmol) and HATU (10.5 mg, 0.0276 mmol). Then, a solution of compound 
18 (15.7 mg, 0.0138 mmol) in DMF (2 mL) was added within 30 minutes.  After being 
stirred at room temperature under Ar atmosphere for 3 hours, the resulting mixture was 
precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, 
and dried in vacuum. Compound 28 was purified by high-performance liquid 
chromatography (Rainin Dynamax C18 83-241-C column, 10-60% methanol in 0.005 M 
ammonium acetate buffer, pH=6.8) and collected as a green solid (10.6 mg, 35%): MS 
(ESI) m/z 736.95[(M-3H)/3]-, 1106.11 [(M-2H)/2]-, (calcd. mass for C111H140N14O26S4: 
2212.89). UV/Vis (MeOH): λmax = 264, 767 nm. 
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H-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-K(IR770)-NH2 (29). Compound 28 (10.6 
mg, 4.79E-3 mmol) was dissolved in DMF (4 mL), followed by the addition of 
diethylamine (1.75 mg, 0.024 mmol). After being stirred at room temperature for 4 hours, 
the resulting mixture was precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 
10 mL), centrifuged down, and freeze-dried. The crude product 29 was collected as a green 
solid and used without further purification: MS (ESI) m/z 995.45 [(M-2H)/2]-, HRMS (m/z) 
664.9516[(M+3H)/3]+, 996.4211 [(M+2H)/2]+, (calcd. mass for C96H130N14O24S4: 
1990.8265). UV/Vis (MeOH): λmax = 773 nm. 
 
Fmoc-dK(Cy55)-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-K(IR770)-NH2(30). 
Compound 15 (3.0 mg, 2.47E-3 mmol) was dissolved in DMF (2 mL), followed by the 
addition of DIPA (3.19 mg, 0.0247 mmol) and HATU (1.41 mg, 3.71E-3 mmol). Then, a 
solution of compound 29 (4.92 mg, 2.47E-3 mmol) in DMF (2 mL) was added within 20 
minutes.  After being stirred at room temperature under Ar atmosphere for 2 hours, the 
resulting mixture was precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 10 
mL), centrifuged down, and dried in vacuum. Compound 30 was purified by high-
performance liquid chromatography (Phenomenex Synergi 10u Polar-RP80 column, 20-
50% methanol in 0.01 M ammonium acetate buffer, pH=6.8) and collected as a green-blue 
solid (3.2 mg, 34%): MS (ESI) m/z 637.09 [(M-5H)/5]-,  797.01[(M-4H)/4]-, 1062.23 [(M-
3H)/3]-, HRMS (m/z) 1061.3981 [(M-3H)/3]-, 1592.6036 [(M-2H)/2]-, (calcd. mass for 
C160H198N18O37S7: 3188.22102). UV/Vis (MeOH): λmax = 685, 775 nm. 
 
F-dK(QC1)-OH (31). Fmoc-dK(H)-OH (1.7 mg, 4.2E-3 mmol) was dissolved in DMF 
(2mL), followed by the addition of DIPA (5.43 mg, 0.042 mmol) and QC1-NHS-ester 
(5.22 mg, 4.2E-3 mmol). After being stirred at room temperature under Ar atmosphere 
for 2 hours, the resulting mixture was precipitated with ether, washed with 1:1 ether/ethyl 
acetate (2 × 10 mL), centrifuged down, and dried in vacuum. Compound 31 was purified 
by high-performance liquid chromatography (Phenomenex Synergi 10u Polar-RP80, 20-
50% methanol in water) and collected as a green-blue solid (5.9 mg, 94%): MS (ESI) m/z 
476.51[(M-3H)/3]-, 714.38 [(M-2H)/2]-, (calcd. mass for C70H84ClN5O17S4: 1429.44). 
UV/Vis (MeOH): λmax = 780 nm (broad). 
 
Fmoc-dK(QC1)-dAla-Pro-Pro-Pro-Pro-K(IR770)-NH2 (32). Compound 31 (3.0 mg, 
2.10E-3 mmol) was dissolved in DMF (2 mL), followed by the addition of DIPA (2.71 mg, 
0.021 mmol) and HATU (1.2 mg, 3.15E-3 mmol). Then, a solution of compound 26 (3.36 
mg, 2.1E-3 mmol) in DMF (2 mL) was added within 20 minutes.  After being stirred at 
room temperature under Ar atmosphere for 3 hours, the resulting mixture was precipitated 
with ether, washed with 1:1 ether/ethyl acetate (2 × 10 mL), centrifuged down, and dried 
in vacuum. Compound 32 was purified by high-performance liquid chromatography 
(Phenomenex Synergi 10u Polar-RP80 column, 20-50% methanol in 0.01 M ammonium 
acetate buffer, pH=6.8) and collected as a green-blue solid (2 mg, 31.6%): MS (ESI) m/z 
1004.67 [(M-3H)/3]-, (calcd. mass for C146H184ClN15O36S8: 3014.05). UV/Vis (MeOH): 
λmax = 771 nm. 
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Fmoc-dK(QC1)-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-K(IR770)-NH2 (33). 
Compound 31 (3.0 mg, 2.10E-3 mmol) was dissolved in DMF (2 mL), followed by the 
addition of DIPA (2.71 mg, 0.021 mmol) and HATU (1.2 mg, 3.15E-3 mmol). Then, a 
solution of compound 29 (4.18 mg, 2.1E-3 mmol) in DMF (2 mL) was added within 20 
minutes.  After being stirred at room temperature under Ar atmosphere for 2 hours, the 
resulting mixture was precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 10 
mL), centrifuged down, and dried in vacuum. Compound 33 was purified by high-
performance liquid chromatography (Phenomenex Synergi 10u Polar-RP80 column, 20-
50% methanol in 0.01 M ammonium acetate buffer, pH=6.8) and collected as a green-blue 
solid (1.0 mg, 14%): MS (ESI) m/z 566.62 [(M-6H)/6]-, 1134.69 [(M-3H)/3]-, (calcd. mass 
for C166H212ClN19O40S48: 3402.26). UV/Vis (MeOH): λmax = 771 nm. 
 
DSS-Lys(Cy5.5)-NH2 (34). Compound 16 (6.0 mg, 6.05E-3 mmol) was dissolved in DMF 
(2 mL), followed by the addition of NMM (3.06 mg, 0.03 mmol) and DSS (11.14 mg, 0.03 
mmol). After being stirred at room temperature under Ar atmosphere for 4 hours, the 
resulting mixture was precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 10 
mL), centrifuged down, and dried in vacuum. The crude product 34 was collected as a blue 
solid and used without further purification: MS (ESI) m/z 600.57 [(M-2H)/2]- in a 0.1% 
butylamine solution, (calcd. mass for C61H76N6O16S3 in a butylamine solution: 1202.51). 
UV/Vis (MeOH): λmax = 682 nm. 
 
DCL-DSS-Lys(Cy5.5)-NH2 (35). Compound 34 (7.5 mg, 6.02E-3 mmol) was dissolved 
in DMF (2 mL), followed by the addition of DIPA (23.35 mg, 0.18 mmol) and DCL (9.61 
mg, 0.03 mmol). After being stirred at room temperature under Ar atmosphere for 4 hours, 
the resulting mixture was precipitated with ether, washed with 1:1 ether/ethyl acetate (2 × 
10 mL), centrifuged down, and dried in vacuum. Compound 35 was purified by high-
performance liquid chromatography (Rainin Dynamax C18 83-241-C column, 20-80% 
methanol in water) and collected as a blue solid (3.0 mg, 34%): MS (ESI) m/z 723.40 [(M-
2H)/2]-,(calcd. mass for C69H92N8O20S3: 1448.56). UV/Vis (MeOH): λmax = 683 nm. 
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Appendix 1:  Analytical Data  
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%
0
100
16_10_10_NG_Fmoc_dAla_PP_Otbu_rxn_1h 322 (5.789) 1: Scan ES+ 
1.55e7562.54
152.17
381.44
579.52
1141.06580.55
581.57 871.82
1143.08
1703.531433.12 1801.24
16_10_10_NG_Fmoc_dAla_PP_Otbu_rxn_1h
nm
200 250 300 350 400 450 500 550
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
5.0e-1
6.0e-1
16_10_10_NG_Fmoc_dAla_PP_Otbu_rxn_1h 1672 (5.570) 3: Diode Array 
7.244e-1208.53
263.53
298.53
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Fmoc-ala-Pro-Pro-OH 4 
 
 
 
 
 
 
 
 
 
Fmoc-Pro-Pro-OH 5 
 
 
 
 
 
 
  
 
 
Fmoc-Pro-Pro-Pro-Pro-Otbu 6 
 
 
 
 
 
 
 
  
  
16_11_16_NG_deOtbu_Fmoc_aPP_OH_rxn_3h
m/z
250 500 750 1000 1250 1500 1750
%
0
100
%
0
100
16_11_16_NG_deOtbu_Fmoc_aPP_OH_rxn_4h 67 (1.201) 2: Scan ES- 
8.69e6113.00
504.44
227.06
326.12
618.36
1009.65620.33 1515.17
1123.88 1669.97
1856.27
16_11_16_NG_deOtbu_Fmoc_aPP_OH_rxn_4h 85 (1.515) 1: Scan ES+ 
1.09e7506.41
499.42
523.44
1028.84524.50
1535.321130.84 1828.261898.91
16_11_16_NG_deOtbu_Fmoc_aPP_OH_rxn_3h
nm
200 250 300 350 400 450 500 550
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
1.0
1.2
16_11_16_NG_deOtbu_Fmoc_aPP_OH_rxn_4h 400 (1.330) 3: Diode Array 
1.569206.53
263.53
16_09_26_NG_deOTBU_Fmoc_PP_Otbu_rxn_a
m/z
250 500 750 1000 1250 1500 1750
%
0
100
%
0
100
16_09_26_NG_deOTBU_Fmoc_PP_Otbu_rxn_a 47 (0.842) 2: Scan ES- 
9.63e6211.18
867.60
547.30433.27
548.33
868.55
1301.89
869.65
1738.111953.37
16_09_26_NG_deOTBU_Fmoc_PP_Otbu_rxn_a 44 (0.779) 1: Scan ES+ 
4.20e7435.32
297.47
886.67
436.31
869.61453.37
887.59
1321.88
888.61
891.73
1322.87 1590.23
1971.16
16_09_26_NG_deOTBU_Fmoc_PP_Otbu_rxn_a
nm
200 250 300 350 400 450 500 550 600
A
U
0.0
2.5e-1
5.0e-1
7.5e-1
1.0
1.25
16_09_26_NG_deOTBU_Fmoc_PP_Otbu_rxn_a 425 (1.413) 3: Diode Array 
1.53206.53
263.53
16_07_15_NG_Tetra_27_47_pure
m/z
500 1000 1500
%
0
100
16_07_15_NG_Tetra_27_47_pure 210 (3.772) 1: Scan ES+ 
2.43e7685.65
629.60
285.46
686.64
687.67
1387.25
759.68 1386.76
1389.34
1652.60
16_07_15_NG_Tetra_27_47_pure
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
16_07_15_NG_Tetra_27_47_pure 1059 (3.527) 3: Diode Array 
5.309e-1206.53
263.53
320.53
758.53
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H-Pro-Pro-Pro-Pro-Otbu 7 
 
 
 
 
 
 
 
Fmoc-ala-Pro-Pro-Pro-Pro-Otbu 8 
 
 
 
 
  
 
 
 
Fmoc-ala-Pro-Pro-Pro-Pro-OH 9 
 
 
 
 
 
 
 
  
16_11_07_NG_Fmoc_aPPPP_Otbu_check
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
16_11_07_NG_Fmoc_aPPPP_Otbu_check 1445 (4.813) 3: Diode Array 
5.647e-1208.53
263.53
298.53
16_11_07_NG_Fmoc_aPPPP_Otbu_check
m/z
250 500 750 1000 1250 1500 1750
%
0
100
16_11_07_NG_Fmoc_aPPPP_Otbu_check 265 (4.760) 1: Scan ES+ 
1.55e7773.66
499.54
141.04
756.41
774.65
775.64
1529.43
797.49
1175.45 1553.561932.66
16_11_16_NG_deOtbu_Fmoc_aPPPP_OH_rxn_3h
m/z
400 500 600 700 800 900 1000
%
0
100
%
0
100
16_11_16_NG_deOtbu_Fmoc_aPPPP_OH_rxn_3h 64 (1.147) 2: Scan ES- 
9.86e5698.57
698.27
698.12379.08
424.19
573.37
812.65699.64
700.55
813.64
814.59
1010.71
16_11_16_NG_deOtbu_Fmoc_aPPPP_OH_rxn_3h 69 (1.228) 1: Scan ES+ 
7.99e6700.59
329.23
330.03 640.62
426.66
619.99
718.60
722.59
814.55
1049.82
912.48
16_11_16_NG_deOtbu_Fmoc_aPPPP_OH_rxn_3h
nm
200 300 400 500 600 700
A
U
0.0
5.0e-1
1.0
1.5
16_11_16_NG_deOtbu_Fmoc_aPPPP_OH_rxn_3h 340 (1.130) 3: Diode Array 
1.867206.53
263.53
16_09_30_NG_defmoc_HPPPPOtbu_rxn_90min
m/z
250 500 750 1000 1250 1500 1750
%
0
100
16_09_30_NG_defmoc_HPPPPOtbu_rxn_90min 100 (1.791) 1: Scan ES+ 
3.07e7463.51
115.01
407.47
464.50
926.01
465.53
925.66 927.34 1569.79
1199.55
1828.79
16_09_30_NG_defmoc_HPPPPOtbu_rxn_90min
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
16_09_30_NG_defmoc_HPPPPOtbu_rxn_90min 523 (1.740) 3: Diode Array 
5.601e-1202.53
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Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Otbu  10 
 
  
 
 
 
 
 
 
Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-OH  11 
 
 
 
 
 
 
 
 
 
Fmoc-Pro-Pro-Pro-Pro-OH 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17_06_09_NG_deOTBU_FaoctaP_OH_rxn_extraTFA_40min_b
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
5.0e-1
6.0e-1
17_06_09_NG_deOTBU_FaoctaP_OH_rxn_extraTFA_40min_b 345 (1.147)3: Diode Array 
7.699e-1206.53
263.53
17_06_09_NG_deOTBU_FaoctaP_OH_rxn_extraTFA_40min_b
m/z
900 1000 1100 1200 1300
%
0
100
%
0
100
17_06_09_NG_deOTBU_FaoctaP_OH_rxn_extraTFA_40min_b 60 (1.075) 1: Scan ES+ 
1.98e61106.02
1089.07
1034.96
1017.97911.91894.73
840.77 912.86 967.81
1088.77
1088.50
1107.85
1110.89 1204.18 1310.791251.65
17_06_09_NG_deOTBU_FaoctaP_OH_rxn_extraTFA_40min_b 61 (1.102) 2: Scan ES- 
1.02e61201.18
1130.12
1086.87
1086.371015.69892.72
936.23
1200.57
1199.97
1131.41
1202.02
1202.28
1203.58 1299.16
17_06_07_NG_SPE_ala_OctPro_402_full_b
m/z
500 1000 1500
%
0
100
17_06_07_NG_SPE_ala_OctPro_402_full_b 169 (3.037)1: Scan ES+ 
2.93e61162.08
572.99
509.72
130.13
1091.13
756.75
772.86
1163.14
1164.01
1168.92
1373.07 1708.51
17_06_07_NG_SPE_ala_OctPro_402_full_b
nm
200 300 400 500 600 700
A
U
0.0
2.0e-2
4.0e-2
6.0e-2
8.0e-2
1.0e-1
17_06_07_NG_SPE_ala_OctPro_402_full_b 913 (3.040) 3: Diode Array 
1.042e-1208.53
263.53
16_09_14_NG_deotbu_F_P_P_P_P_OH_
m/z
500 1000 1500
%
0
100
%
0
100
16_09_14_NG_deotbu_F_P_P_P_P_OH_ 133 (2.390) 2: Scan ES- 
4.52e6627.59
627.13
626.72113.07
1256.52628.35
1255.19741.32 1885.951258.00
16_09_14_NG_deotbu_F_P_P_P_P_OH_ 136 (2.435) 1: Scan ES+ 
8.83e6629.64
435.40
630.63
647.69 1276.24 1800.14
16_09_14_NG_deotbu_F_P_P_P_P_OH_
nm
200 250 300 350 400 450 500
A
U
0.0
5.0e-1
1.0
16_09_14_NG_deotbu_F_P_P_P_P_OH_ 744 (2.477)
1.471208.53
263.53
298.53
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Fmoc-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Otbu 13 
 
 
 
 
H-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Otbu 14 
 
 
 
 
 
 
 
 
 
 
 
 
Fmoc-dK(Cy55)-OH  15 
 
 
  
17_05_08_NG_F_PPPPPPPP_Otbu_rxn_extra
nm
200 300 400 500 600 700
A
U
0.0
2.5e-1
5.0e-1
7.5e-1
1.0
1.25
17_05_08_NG_F_PPPPPPPP_Otbu_rxn_extra 673 (2.240) 3: Diode Array 
1.629218.53
263.53
298.53
16_07_20_NG_F_KCY60_OH_afterether_a
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
16_07_20_NG_F_KCY60_OH_afterether_a 206 (1.708)3: Diode Array 
6.758e-1682.53
227.53
353.53
17_05_08_NG_F_PPPPPPPP_Otbu_rxn_extra
m/z
600 800 1000 1200 1400
%
0
100
17_05_08_NG_F_PPPPPPPP_Otbu_rxn_extra 209 (3.772) 1: Scan ES+ 
9.91e61090.86
896.78
879.61
835.41
684.70
1073.87
897.73
901.91
1091.85
1093.14
1111.91
1240.63 1454.37
17_05_11_NG_defmoc_H_PPPPPPPP_Otbu_rxn_250
m/z
200 400 600 800 1000 1200 1400 1600 1800
%
0
100
17_05_11_NG_defmoc_H_PPPPPPPP_Otbu_rxn_250 51 (0.911) Cm (50:64)1: Scan ES+ 
1.95e7851.72
115.13
398.54
130.15
268.29
578.50
579.54
658.61
852.67
853.72
854.76
1314.091091.86 1703.451508.73
1849.71
17_05_11_NG_defmoc_H_PPPPPPPP_Otbu_rxn_250
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
17_05_11_NG_defmoc_H_PPPPPPPP_Otbu_rxn_250 284 (0.943) 3: Diode Array 
1.048216.53
16_07_20_NG_F_KCY60_OH_afterether_a
m/z
500 1000 1500 2000
%
0
100
%
0
100
16_07_20_NG_F_KCY60_OH_afterether_a 38 (1.324)2: Scan ES+ 
4.02e6369.30
1215.80
370.34
538.48
865.66
1217.79
1537.83 1824.70
16_07_20_NG_F_KCY60_OH_afterether_a 46 (1.585) 1: Scan ES- 
1.31e6606.52
606.21113.05 607.17
809.76
1215.26 1379.00 1643.75 1869.17
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H-dK(Cy55)-NH2 16 
  
 
 
 
 
 
 
 
Fmoc-dK(IR770TI)-OH 17a 
 
 
 
 
 
 
 
 
 
Fmoc-K(IR770TI)- NH2 17b  
 
 
 
 
 
 
 
 
  
16_10_04_NG_F_dK(IR7700)_NH2_water
m/z
400 600 800 1000 1200 1400 1600
%
0
100
%
0
100
16_10_04_NG_F_dK(IR7700)_NH2_water 115 (3.989) 2: Scan ES+ 
6.87e5693.10
685.19
684.35
391.50
929.52
923.84
923.61
935.59
1425.66
947.95
1367.90 1433.23
1513.22
16_10_04_NG_F_dK(IR7700)_NH2_water 115 (3.972) 1: Scan ES- 
5.56e6454.85
454.20
682.54455.24
455.89
910.82
683.16
690.80
911.17
1366.521025.29 1425.05
16_10_04_NG_F_dK(IR7700)_NH2_water
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
16_10_04_NG_F_dK(IR7700)_NH2_water 480 (3.992) 3: Diode Array 
4.843e-1770.53
203.53
263.53
383.53
17_02_28_NG_democ_H_dK(cy55)_nh2_rxn_2h
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_02_28_NG_democ_H_dK(cy55)_nh2_rxn_2h 147 (5.113) 2: Scan ES+ 
1.77e6303.23
333.29
497.05
992.46
497.82 696.67
1905.80
1746.511502.39
17_02_28_NG_democ_H_dK(cy55)_nh2_rxn_2h 145 (5.026) 1: Scan ES- 
3.73e6118.96
494.86
120.00
660.12
990.73 1239.26 1739.481487.07 1989.48
17_02_28_NG_democ_H_dK(cy55)_nh2_rxn_2h
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
17_02_28_NG_democ_H_dK(cy55)_nh2_rxn_2h 644 (5.358) 3: Diode Array 
4.38e-1682.53
225.53
353.53
17_02_09_NG_F_dK(IR770_NH2_rxn_20min
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_02_09_NG_F_dK(IR770_NH2_rxn_20min 158 (5.490) 2: Scan ES+ 
9.02e6683.89
147.11 683.43
693.10
693.56923.15
917.77
1423.631655.231885.68
17_02_09_NG_F_dK(IR770_NH2_rxn_20min 158 (5.473) 1: Scan ES- 
5.85e6682.05
454.39
118.81
119.23
454.93
682.81
909.32
910.28 1367.25 1849.811614.98
17_02_09_NG_F_dK(IR770_NH2_rxn_20min
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
17_02_09_NG_F_dK(IR770_NH2_rxn_20min 603 (5.017) 3: Diode Array 
1.0
775.53
263.53
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H-dK(IR770TI)- NH2 18 
 
 
 
 
 
 
  
 
 
 
  
 
 
Fmoc-Pro-Pro-K(Cy55)-NH2  19 
 
 
 
 
 
 
 
H-Pro-Pro-K(Cy55)-NH2   20 
 
 
 
 
 
 
 
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min
nm
200 300 400 500 600 700
A
U
0.0
5.0e-2
1.0e-1
1.5e-1
2.0e-1
2.5e-1
3.0e-1
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min 556 (4.625)
3.0e-1
773.53
381.53
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min 117 (4.064) 2: Scan ES+ 
1.02e7573.00
572.50
230.00
1144.72
573.96 769.29
872.65
1146.14
1179.28 1561.03 1638.06 1997.31
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min 119 (4.116) 1: Scan ES- 
7.31e6570.96
570.58380.32
119.04 381.28
571.50
1143.53572.04 762.34
1429.65 1715.33
1886.91
16_06_10_NG_Fmoc_Pro_Pro_KCY55_prepHPLC_27-37
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
16_06_10_NG_Fmoc_Pro_Pro_KCY55_prepHPLC_27-37 34 (1.183) 2: Scan ES+ 
9.45e5141.19
1408.80
713.72
146.19
713.22
269.48 704.58
1408.46715.87
727.59 1407.96939.51
1409.95
1906.26
1716.56
16_06_10_NG_Fmoc_Pro_Pro_KCY55_prepHPLC_27-37 33 (1.130) 1: Scan ES- 
6.04e6703.01
702.47
702.17
119.04 701.78
328.41
937.70
704.58 1406.77938.16
1487.68
1759.99
16_06_10_NG_Fmoc_Pro_Pro_KCY55_prepHPLC_27-37
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
5.0e-1
6.0e-1
16_06_10_NG_Fmoc_Pro_Pro_KCY55_prepHPLC_27-37 153 (1.267)
7.247e-1682.53
227.53
353.53
06_13_16_NG_DeproFmoc_H_P_P_K(CY55)_NH2_rxn_30min_c
m/z
300 400 500 600 700 800 900 1000
%
0
100
%
0
100
06_13_16_NG_DeproFmoc_H_P_P_K(CY55)_NH2_rxn_30min_c 81 (2.821) 2: Scan ES- 
1.32e6592.20
591.82
591.40
369.58
524.76
592.85
633.96
790.05 831.05 942.12 1069.65
06_13_16_NG_DeproFmoc_H_P_P_K(CY55)_NH2_rxn_30min_c 87 (3.013) 1: Scan ES+ 
3.83e6593.91
593.57
444.35349.29 481.40
594.59
594.78
605.61
631.18 727.47 822.12 896.37
1034.20
06_13_16_NG_DeproFmoc_H_P_P_K(CY55)_NH2_rxn_30min_c
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
06_13_16_NG_DeproFmoc_H_P_P_K(CY55)_NH2_rxn_30min_c 406 (3.375)
5.0e-1
682.53
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
5.0e-1
6.0e-1
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min 458 (3.808)
6.0e-1
613.53
310.53 768.53
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min
Time
1.00 2.00 3.00 4.00 5.00
A
U
0.0
2.0e+2
4.0e+2
6.0e+2
17_05_02_NG_defmoc_H_dK(IR770)_NH2_120min 3: Diode Array 
Range: 9.405e+24.08
1.26
5.01
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Fmoc-dK(IR770TI)-Pro-Pro-K(Cy55)-NH2   21 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fmoc-ala-Pro-Pro-dK(IR770TI)-NH2  22  
 
 
 
 
 
 
 
H-ala-Pro-Pro-dK(IR770TI)-NH2  23 
 
 
 
 
 
 
16_12_07_NG_F_aPP_dK(IR770)_NH2_prep_70
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
16_12_07_NG_F_aPP_dK(IR770)_NH2_prep_70 129 (4.473) 2: Scan ES+ 
2.08e6816.48
816.09180.20 388.27
817.24
834.22
1117.64
860.83
1259.92
1694.02 1925.62
16_12_07_NG_F_aPP_dK(IR770)_NH2_prep_70 130 (4.491) 1: Scan ES- 
3.51e6542.74
118.92
119.19 541.97
120.11
814.83
813.94
543.66
1086.35
1086.08
1087.69 1629.92 1980.22
16_12_14_NG_F_aPP_dK(IR770)_NH2_prep_70
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
16_12_14_NG_F_aPP_dK(IR770)_NH2_prep_70 159 (1.317) 3: Diode Array 
1.0
775.53
208.53
17_01_08_NG_defmoc_H_a_P_P_dK(IR770)_NH2_rxn_2h_b
m/z
200 400 600 800 1000 1200 1400 1600 1800
%
0
100
%
0
100
17_01_08_NG_defmoc_H_a_P_P_dK(IR770)_NH2_rxn_2h_b 194 (3.493) 2: Scan ES+ 
8.60e6147.12
705.60
705.22
148.07
559.23395.04
714.30
714.65 951.96
727.98 1444.681080.60 1738.65 1947.07
17_01_08_NG_defmoc_H_a_P_P_dK(IR770)_NH2_rxn_2h_b 193 (3.466) 1: Scan ES- 
3.66e6703.48
119.00
468.45
467.88
703.06
469.40
703.82
938.51704.80
1408.46939.31
1347.76 1725.31 1805.31
17_01_08_NG_defmoc_H_a_P_P_dK(IR770)_NH2_rxn_2h_b
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
5.0e-1
6.0e-1
17_01_08_NG_defmoc_H_a_P_P_dK(IR770)_NH2_rxn_2h_b 459 (3.817) 3: Diode Array 
7.0e-1
775.53
201.53
381.53
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b
m/z
200 400 600 800 1000 1200 1400 1600 1800 2000
%
0
100
%
0
100
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b 124 (4.295) 2: Scan ES+ 
2.45e6846.50
845.24
304.15 696.87
1277.62
1268.48
857.26
857.83
1268.14
863.21
863.71 1267.87
1278.39
1303.54
1303.77 1567.06 1731.27
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b 125 (4.313) 1: Scan ES- 
7.53e6844.12
118.96
632.59
506.11
119.88
844.55
844.89
1267.21
845.39
1266.06 1275.62
1528.04
1700.70
1930.49
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
5.0e-2
1.0e-1
1.5e-1
2.0e-1
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b 558 (4.642) 3: Diode Array 
2.695e-1682.53
227.53
364.53
777.53
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b
Time
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
A
U
0.0
2.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
A
U
0.0
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
A
U
0.0
1.0
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b F3
770
Range: 1.43
4.34
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b F3
680
Range: 1.793
4.35
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b F3
Range: 2.902e+24.34
17_01_09_NG_Fmoc_dK(IR770)_PP_dK(CY55)_NH2_prep35_b 1: Scan ES- 
844
1.17e7
4.28
4.59
 91 
 
Fmoc-dK(Cy55)-ala-Pro-Pro-dK(IR770TI)-NH2  24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fmoc-ala-Pro-Pro-Pro-Pro-dK(IR770TI)-NH2  25 
 
 
 
 
 
 
 
H-ala-Pro-Pro-Pro-Pro-dK(IR770TI)-NH2  26 
 
 
 
 
 
17_01_11_NG_F_aPPPP_dk(IR770)_NH2_rxn_overnight_b
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_01_11_NG_F_aPPPP_dk(IR770)_NH2_rxn_overnight_b 132 (4.575) 2: Scan ES+ 
1.14e7913.97
913.51
913.13
720.33316.16
922.38
923.19
1246.09 1505.77 1881.92
17_01_11_NG_F_aPPPP_dk(IR770)_NH2_rxn_overnight_b 135 (4.662) 1: Scan ES- 
2.16e6911.55
608.13
112.93
606.94119.00
606.86
140.69
478.23
608.98
912.55
1216.53913.05
1215.64 1217.14 1831.69
1718.75
1899.54
17_01_11_NG_F_aPPPP_dk(IR770)_NH2_rxn_overnight_b
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
1.0
1.2
17_01_11_NG_F_aPPPP_dk(IR770)_NH2_rxn_overnight_b 557 (4.633) 3: Diode Array 
1.211770.53
201.53
263.53
17_01_17_NG_defmoc_H_aPPPP_dK(IR773)_rxn_90min
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_01_17_NG_defmoc_H_aPPPP_dK(IR773)_rxn_90min 108 (3.746) 2: Scan ES+ 
4.82e6802.81
802.23
608.25147.18
803.23
812.10 1216.56 1615.64 1708.68
1953.69
17_01_17_NG_defmoc_H_aPPPP_dK(IR773)_rxn_90min 110 (3.798) 1: Scan ES- 
4.63e6119.00
179.05
800.77607.44180.28 1306.42
945.23
1515.14 1760.30
1881.11
17_01_17_NG_defmoc_H_aPPPP_dK(IR773)_rxn_90min
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
17_01_17_NG_defmoc_H_aPPPP_dK(IR773)_rxn_90min 488 (4.058)3: Diode Array 
1.0
773.53
228.53
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb
m/z
200 400 600 800 1000 1200 1400 1600 1800 2000
%
0
100
%
0
100
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 123 (4.269) 2: Scan ES+ 
6.98e5881.22
875.57
869.20
138.01
303.26
472.40 654.59
881.68
1330.19
887.94
1148.40982.24 1890.861596.93
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 127 (4.391) 1: Scan ES- 
1.41e6118.92
119.19 867.97
458.58
227.09
866.62
459.61
868.74
1302.89868.97 1756.88
1459.38
1817.94
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
2.5e-2
5.0e-2
7.5e-2
1.0e-1
1.25e-1
1.5e-1
1.75e-1
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 526 (4.375) 3: Diode Array 
2.143e-1683.53
227.53
364.53
777.53
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb
Time
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
A
U
0.0
2.0e+1
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
A
U
0.0
2.0e-1
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00
A
U
0.0
1.0e-1
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 3: Diode Array 
770
Range: 1.924e-1
4.38
1.07
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 3: Diode Array 
680
Range: 2.172e-1
4.42
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 3: Diode Array 
Range: 3.404e+14.38
1.07 2.88
17_01_13_NG_prep_F_dK(CY55)_aPP_dK(IR770)_NH2_84_fullb 1: Scan ES- 
867
2.11e6
4.29
4.43
5.78
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Fmoc-dK(Cy55)-ala-Pro-Pro-Pro-Pro-dK(IR770TI)-NH2  27 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fmoc-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-dK(IR770TI)-NH2  28 
 
 
 
 
 
 
 
H-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-dK(IR770TI)-NH2   29 
 
 
 
 
 
17_06_15_NG_F_aPPPPPPPP_dKIR770_NH2_prep_89
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_06_15_NG_F_aPPPPPPPP_dKIR770_NH2_prep_89 147 (5.106)2: Scan ES+ 
2.65e6739.10
721.33
152.10 714.68
306.30
739.83
1081.51740.14
1072.25
1126.36 1343.52 1868.131968.62
17_06_15_NG_F_aPPPPPPPP_dKIR770_NH2_prep_89 148 (5.124) 1: Scan ES- 
2.43e6736.95
118.96
712.96
712.34
140.96
1106.66
1070.91
1069.83
738.03
972.95
1107.04
1451.81
1116.88 1624.01
1794.67
17_06_15_NG_F_aPPPPPPPP_dKIR770_NH2_prep_89
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
5.0e-1
1.0
1.5
17_06_15_NG_F_aPPPPPPPP_dKIR770_NH2_prep_89 615 (5.117) 3: Diode Array 
2.0
766.53
206.53
263.53
383.53
17_06_21_NG_defmoc_H_alaocta_IR770_rxn_extraDEA_90min_b
m/z
200 400 600 800 1000 1200 1400 1600 1800 2000
%
0
100
%
0
100
17_06_21_NG_defmoc_H_alaocta_IR770_rxn_extraDEA_91min_d 79 (2.744)2: Scan ES+ 
1.68e6665.42
665.11
641.92
147.22
600.07
671.06
961.59676.71
908.56
1005.86
1013.27
1259.53
1769.97
1890.79
17_06_21_NG_defmoc_H_alaocta_IR770_rxn_extraDEA_91min_d 78 (2.692) 1: Scan ES- 
2.31e6995.45
994.88118.96
994.69
959.63
663.31
638.46178.82
898.04
996.26
996.53 1327.31
2002.65
1493.59
1939.52
17_06_21_NG_defmoc_H_alaocta_IR770_rxn_extraDEA_90min_b
nm
200 250 300 350 400 450 500 550 600 650 700 750
A
U
0.0
5.0e-2
1.0e-1
1.5e-1
2.0e-1
2.5e-1
3.0e-1
17_06_21_NG_defmoc_H_alaocta_IR770_rxn_extraDEA_91min_d 852 (2.837) 3: Diode Array 
3.46e-1775.53
213.53
17_01_23_NG_2ndprep_Tetradualdye_49_b
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_01_23_NG_2ndprep_Tetradualdye_49_b 121 (4.196) Cm (117:123) 2: Scan ES+ 
2.83e6940.38
934.54
679.56
367.23
933.90
946.00
951.98
952.88
1401.46 1655.95
1765.41
1926.00
17_01_23_NG_2ndprep_Tetradualdye_49_b 122 (4.214) Cm (120:125) 1: Scan ES- 
2.19e6932.61118.98
699.28559.08140.94
699.95
933.53
934.28
1399.371302.33 1700.49
1889.70
17_01_23_NG_2ndprep_Tetradualdye_49_b
Time
0.00 2.00 4.00 6.00
%
0
100
0.00 2.00 4.00 6.00
A
U
0.0
0.00 2.00 4.00 6.00
A
U
0.0
1.0
0.00 2.00 4.00 6.00
A
U
0.0
1.0
17_01_23_NG_2ndprep_Tetradualdye_49_b 3: Diode Array 
770
Range: 1.106
4.16
17_01_23_NG_2ndprep_Tetradualdye_49_b 3: Diode Array 
680
Range: 1.186
4.16
17_01_23_NG_2ndprep_Tetradualdye_49_b 3: Diode Array 
Range: 1.957e+24.16
17_01_23_NG_2ndprep_Tetradualdye_49_b 1: Scan ES- 
932
1.77e6
4.25
4.07
4.53
17_01_23_NG_2ndprep_Tetradualdye_49_b
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
17_01_23_NG_2ndprep_Tetradualdye_49_b 508 (4.225) 3: Diode Array 
9.0e-1
685.53
227.53
364.53
773.53
 93 
 
Fmoc-dK(Cy55)-ala-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-dK(IR770TI)-NH2  30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F-dK(QC1)-OH 31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17_07_12_NG_prep_QC1puzzlepiece_25_full
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_07_12_NG_prep_QC1puzzlepiece_25_full 121 (4.197) 2: Scan ES+ 
3.01e6724.67
304.38 715.91
333.33
725.97
961.32
727.24
978.56 1455.84 1952.96
17_07_12_NG_prep_QC1puzzlepiece_25_full 124 (4.284) 1: Scan ES- 
1.53e6476.51
475.62
119.08
301.54
476.93 714.38
477.24 953.64 1072.48
1443.21 1954.921532.00
17_07_12_NG_prep_QC1puzzlepiece_25_full
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
17_07_12_NG_prep_QC1puzzlepiece_25_full 1280 (4.263) 3: Diode Array 
4.0e-1
220.53
263.53
17_06_30_NG_octa_dualdye_prep_25_full
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
4.0e-1
5.0e-1
6.0e-1
17_06_30_NG_octa_dualdye_prep_25_full 1076 (3.583) 3: Diode Array 
6.0e-1
685.53
227.53
364.53
775.53
17_06_30_NG_octa_dualdye_prep_25_full
Time
1.00 2.00 3.00 4.00 5.00
%
0
100
1.00 2.00 3.00 4.00 5.00
%
0
100
1.00 2.00 3.00 4.00 5.00
A
U
0.0
5.0e+1
1.00 2.00 3.00 4.00 5.00
A
U
0.0
5.0e-1
17_06_30_NG_octa_dualdye_prep_25_full 3: Diode Array 
680
Range: 5.387e-1
3.54
0.99 4.07
17_06_30_NG_octa_dualdye_prep_25_full 3: Diode Array 
Range: 8.851e+13.54
0.99
17_06_30_NG_octa_dualdye_prep_25_full 1: Scan ES- 
TIC
1.30e7
3.52
0.950.33 1.991.44 3.102.44
4.494.35
4.80
17_06_30_NG_octa_dualdye_prep_25_full 1: Scan ES- 
1062
1.46e6
3.48
17_06_30_NG_octa_dualdye_prep_25_full
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_06_30_NG_octa_dualdye_prep_25_full 101 (3.499) 2: Scan ES+ 
1.87e6304.38
303.23
1070.79
1064.73
334.25
1053.13
1081.16
1087.54
1311.72
1619.67 1873.31
17_06_30_NG_octa_dualdye_prep_25_full 102 (3.517) 1: Scan ES- 
9.04e5119.00
637.08
119.27 636.74
141.08
636.51
179.09
1062.23
797.01
1061.96
797.62
1063.11
1063.31
1063.46
1594.25
1070.03 1852.42
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Fmoc-dK(QC1)-dAla-Pro-Pro-Pro-Pro-dK(IR770)-NH2 32 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fmoc-dK(QC1)-dAla-Pro-Pro-Pro-Pro-Pro-Pro-Pro-Pro-K(IR770)-NH2 33 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
17_07_22_NG_prep_tetraQC1IR770_108
Time
0.00 1.00 2.00 3.00 4.00 5.00 6.00
%
0
100
0.00 1.00 2.00 3.00 4.00 5.00 6.00
%
0
100
0.00 1.00 2.00 3.00 4.00 5.00 6.00
A
U
0.0
2.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00
A
U
0.0
17_07_22_NG_prep_tetraQC1IR770_108 3: Diode Array 
770
Range: 1.725
4.09
17_07_22_NG_prep_tetraQC1IR770_108 3: Diode Array 
Range: 2.377e+24.08
1.41
17_07_22_NG_prep_tetraQC1IR770_108 1: Scan ES- 
1004
3.99e7
4.12
17_07_22_NG_prep_tetraQC1IR770_108 1: Scan ES- 
TIC
2.22e8
4.12
17_07_22_NG_prep_tetraQC1IR770_108
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_07_22_NG_prep_tetraQC1IR770_108 121 (4.205) 2: Scan ES+ 
2.27e61029.59
1006.97
304.45
303.42
1006.28781.15
305.34
755.19 789.02
1035.66
1252.70
1253.35 1564.64
1771.55
17_07_22_NG_prep_tetraQC1IR770_108 118 (4.083) 1: Scan ES- 
2.03e71004.67
1004.09
1003.59602.22
501.85
501.31 1003.33
1005.17
1005.48
1006.47
1507.73 1834.22
17_07_22_NG_prep_tetraQC1IR770_108
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
1.0
1.2
17_07_22_NG_prep_tetraQC1IR770_108 1209 (4.027) 3: Diode Array 
1.394768.53
204.53
17_07_17_NG_octa_QC1_IR770_63_fulla
nm
200 300 400 500 600 700
A
U
0.0
2.0e-1
4.0e-1
6.0e-1
8.0e-1
17_07_17_NG_octa_QC1_IR770_63_fulla 1224 (4.077) 3: Diode Array 
1.03771.53
209.53
17_07_17_NG_octa_QC1_IR770_63_fulla
Time
0.00 1.00 2.00 3.00 4.00 5.00 6.00
%
0
100
0.00 1.00 2.00 3.00 4.00 5.00 6.00
%
0
100
0.00 1.00 2.00 3.00 4.00 5.00 6.00
A
U
0.0
1.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00
A
U
0.0
1.0
17_07_17_NG_octa_QC1_IR770_63_fulla 3: Diode Array 
770
Range: 1.184
4.11
17_07_17_NG_octa_QC1_IR770_63_fulla 3: Diode Array 
Range: 1.36e+24.11
1.83
0.00
17_07_17_NG_octa_QC1_IR770_63_fulla 1: Scan ES- 
1134
1.84e6
4.07
17_07_17_NG_octa_QC1_IR770_63_fulla 1: Scan ES- 
TIC
2.88e7
4.07
1.26 2.892.16 5.745.18
17_07_17_NG_octa_QC1_IR770_63_fullb
m/z
500 1000 1500 2000
%
0
100
%
0
100
17_07_17_NG_octa_QC1_IR770_63_fullb 116 (4.020) 2: Scan ES+ 
1.43e61148.17856.60
304.38
852.53
852.30386.58
869.62
1136.23
1153.16
1397.43
1742.09
17_07_17_NG_octa_QC1_IR770_63_fullb 117 (4.038) 1: Scan ES- 
2.81e6566.62
119.00
534.29
1134.69
850.54
680.39 1133.85
851.53 1135.35
1706.651140.95 1815.21
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DSS-Lys(Cy5.5)-NH2 34 
 
 
 
 
 
 
 
 
 
 
 
 
DCL-DSS-Lys(Cy5.5)-NH2 35 
 
 
17_04_04_NG_dss_dK(CY55)_NH2_rxn_overnight_b
m/z
250 500 750 1000 1250 1500 1750 2000
%
0
100
%
0
100
17_04_04_NG_dss_dK(CY55)_NH2_rxn_overnight_b 137 (4.743)1: Scan ES- 
1.93e6119.00
600.68
389.69119.88 601.10 801.08 1202.89 1462.26 1863.25
17_04_04_NG_dss_dK(CY55)_NH2_rxn_overnight_b 138 (4.778)1: Scan ES- 
1.85e6119.04 600.57
599.88
599.34120.11
601.07
801.27
799.89 1202.12
802.19 1981.641505.96
17_04_04_NG_dss_dK(CY55)_NH2_rxn_overnight_b
nm
200 300 400 500 600 700
A
U
0.0
2.5e-1
5.0e-1
7.5e-1
1.0
1.25
1.5
1.75
17_04_04_NG_dss_dK(CY55)_NH2_rxn_overnight_b 582 (4.842)
2.197682.53
227.53
353.53
17_04_13_NG_DCL_DSS_Cy55_prep_42_full_b
m/z
400 500 600 700 800 900 1000 1100
%
0
100
%
0
100
17_04_13_NG_DCL_DSS_Cy55_prep_42_full_b 112 (3.892) 2: Scan ES+ 
3.56e5725.51
391.42
697.83
406.47 616.27
726.70
799.39
800.35
989.85 1019.53
17_04_13_NG_DCL_DSS_Cy55_prep_42_full_b 113 (3.910) 1: Scan ES- 
1.17e5723.40
482.54
424.10
722.55505.46
724.86
963.93900.72801.31
1041.73
17_04_13_NG_DCL_DSS_Cy55_prep_42_full_b
nm
200 300 400 500 600 700
A
U
0.0
1.0e-1
2.0e-1
3.0e-1
17_04_13_NG_DCL_DSS_Cy55_prep_42_full_b 474 (3.942)3: Diode Array 
4.129e-1683.53
228.53
363.53
